{"prices": {"current_page": 1, "total_pages": 1, "page_size": 50000, "api_call_credits": 1, "data": [{"ex_dividend": 0.0, "volume": 67950.0, "adj_low": 2.55, "adj_open": 2.55, "adj_close": 2.55, "high": 2.6, "adj_volume": 67950.0, "low": 2.55, "date": "2017-02-06", "close": 2.55, "open": 2.55, "adj_high": 2.6, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 90752.0, "adj_low": 2.55, "adj_open": 2.6, "adj_close": 2.55, "high": 2.65, "adj_volume": 90752.0, "low": 2.55, "date": "2017-02-03", "close": 2.55, "open": 2.6, "adj_high": 2.65, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 143181.0, "adj_low": 2.5, "adj_open": 2.6, "adj_close": 2.55, "high": 2.6, "adj_volume": 143181.0, "low": 2.5, "date": "2017-02-02", "close": 2.55, "open": 2.6, "adj_high": 2.6, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 88608.0, "adj_low": 2.55, "adj_open": 2.75, "adj_close": 2.55, "high": 2.75, "adj_volume": 88608.0, "low": 2.55, "date": "2017-02-01", "close": 2.55, "open": 2.75, "adj_high": 2.75, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 90999.0, "adj_low": 2.5, "adj_open": 2.55, "adj_close": 2.65, "high": 2.675, "adj_volume": 90999.0, "low": 2.5, "date": "2017-01-31", "close": 2.65, "open": 2.55, "adj_high": 2.675, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 54432.0, "adj_low": 2.5, "adj_open": 2.55, "adj_close": 2.55, "high": 2.6, "adj_volume": 54432.0, "low": 2.5, "date": "2017-01-30", "close": 2.55, "open": 2.55, "adj_high": 2.6, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 71009.0, "adj_low": 2.5, "adj_open": 2.55, "adj_close": 2.55, "high": 2.65, "adj_volume": 71009.0, "low": 2.5, "date": "2017-01-27", "close": 2.55, "open": 2.55, "adj_high": 2.65, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 86375.0, "adj_low": 2.5, "adj_open": 2.55, "adj_close": 2.6, "high": 2.65, "adj_volume": 86375.0, "low": 2.5, "date": "2017-01-26", "close": 2.6, "open": 2.55, "adj_high": 2.65, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 67353.0, "adj_low": 2.475, "adj_open": 2.6, "adj_close": 2.6, "high": 2.65, "adj_volume": 67353.0, "low": 2.475, "date": "2017-01-25", "close": 2.6, "open": 2.6, "adj_high": 2.65, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 106965.0, "adj_low": 2.35, "adj_open": 2.55, "adj_close": 2.6, "high": 2.6, "adj_volume": 106965.0, "low": 2.35, "date": "2017-01-24", "close": 2.6, "open": 2.55, "adj_high": 2.6, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 119274.0, "adj_low": 2.55, "adj_open": 2.55, "adj_close": 2.55, "high": 2.65, "adj_volume": 119274.0, "low": 2.55, "date": "2017-01-23", "close": 2.55, "open": 2.55, "adj_high": 2.65, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 202566.0, "adj_low": 2.5, "adj_open": 2.6, "adj_close": 2.6, "high": 2.65, "adj_volume": 202566.0, "low": 2.5, "date": "2017-01-20", "close": 2.6, "open": 2.6, "adj_high": 2.65, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 171264.0, "adj_low": 2.55, "adj_open": 2.65, "adj_close": 2.55, "high": 2.65, "adj_volume": 171264.0, "low": 2.55, "date": "2017-01-19", "close": 2.55, "open": 2.65, "adj_high": 2.65, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 292664.0, "adj_low": 2.6, "adj_open": 2.85, "adj_close": 2.65, "high": 2.85, "adj_volume": 292664.0, "low": 2.6, "date": "2017-01-18", "close": 2.65, "open": 2.85, "adj_high": 2.85, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 137494.0, "adj_low": 2.8, "adj_open": 3.0, "adj_close": 2.85, "high": 3.0, "adj_volume": 137494.0, "low": 2.8, "date": "2017-01-17", "close": 2.85, "open": 3.0, "adj_high": 3.0, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 346920.0, "adj_low": 2.85, "adj_open": 2.85, "adj_close": 3.0, "high": 3.01, "adj_volume": 346920.0, "low": 2.85, "date": "2017-01-13", "close": 3.0, "open": 2.85, "adj_high": 3.01, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 130109.0, "adj_low": 2.8, "adj_open": 2.8, "adj_close": 2.85, "high": 2.9, "adj_volume": 130109.0, "low": 2.8, "date": "2017-01-12", "close": 2.85, "open": 2.8, "adj_high": 2.9, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 212248.0, "adj_low": 2.755, "adj_open": 2.85, "adj_close": 2.85, "high": 2.9, "adj_volume": 212248.0, "low": 2.755, "date": "2017-01-11", "close": 2.85, "open": 2.85, "adj_high": 2.9, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 233091.0, "adj_low": 2.8, "adj_open": 2.95, "adj_close": 2.85, "high": 2.95, "adj_volume": 233091.0, "low": 2.8, "date": "2017-01-10", "close": 2.85, "open": 2.95, "adj_high": 2.95, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 446825.0, "adj_low": 2.7, "adj_open": 2.7, "adj_close": 2.95, "high": 3.0, "adj_volume": 446825.0, "low": 2.7, "date": "2017-01-09", "close": 2.95, "open": 2.7, "adj_high": 3.0, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 188194.0, "adj_low": 2.6, "adj_open": 2.7, "adj_close": 2.7, "high": 2.75, "adj_volume": 188194.0, "low": 2.6, "date": "2017-01-06", "close": 2.7, "open": 2.7, "adj_high": 2.75, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 477154.0, "adj_low": 2.475, "adj_open": 2.55, "adj_close": 2.7, "high": 2.7, "adj_volume": 477154.0, "low": 2.475, "date": "2017-01-05", "close": 2.7, "open": 2.55, "adj_high": 2.7, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 679774.0, "adj_low": 2.5, "adj_open": 2.5, "adj_close": 2.55, "high": 2.65, "adj_volume": 679774.0, "low": 2.5, "date": "2017-01-04", "close": 2.55, "open": 2.5, "adj_high": 2.65, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 939543.0, "adj_low": 2.36, "adj_open": 2.45, "adj_close": 2.5, "high": 2.537, "adj_volume": 939543.0, "low": 2.36, "date": "2017-01-03", "close": 2.5, "open": 2.45, "adj_high": 2.537, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 2594376.0, "adj_low": 2.35, "adj_open": 2.45, "adj_close": 2.45, "high": 2.525, "adj_volume": 2594376.0, "low": 2.35, "date": "2016-12-30", "close": 2.45, "open": 2.45, "adj_high": 2.525, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 203166.0, "adj_low": 2.4, "adj_open": 2.5, "adj_close": 2.45, "high": 2.5, "adj_volume": 203166.0, "low": 2.4, "date": "2016-12-29", "close": 2.45, "open": 2.5, "adj_high": 2.5, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 534932.0, "adj_low": 2.375, "adj_open": 2.45, "adj_close": 2.5, "high": 2.575, "adj_volume": 534932.0, "low": 2.375, "date": "2016-12-28", "close": 2.5, "open": 2.45, "adj_high": 2.575, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 328583.0, "adj_low": 2.45, "adj_open": 2.45, "adj_close": 2.5, "high": 2.55, "adj_volume": 328583.0, "low": 2.45, "date": "2016-12-27", "close": 2.5, "open": 2.45, "adj_high": 2.55, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 367313.0, "adj_low": 2.45, "adj_open": 2.55, "adj_close": 2.5, "high": 2.6, "adj_volume": 367313.0, "low": 2.45, "date": "2016-12-23", "close": 2.5, "open": 2.55, "adj_high": 2.6, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 146923.0, "adj_low": 2.55, "adj_open": 2.6, "adj_close": 2.55, "high": 2.7, "adj_volume": 146923.0, "low": 2.55, "date": "2016-12-22", "close": 2.55, "open": 2.6, "adj_high": 2.7, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 444289.0, "adj_low": 2.5, "adj_open": 2.7, "adj_close": 2.6, "high": 2.7, "adj_volume": 444289.0, "low": 2.5, "date": "2016-12-21", "close": 2.6, "open": 2.7, "adj_high": 2.7, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 401239.0, "adj_low": 2.6, "adj_open": 2.6, "adj_close": 2.7, "high": 2.74, "adj_volume": 401239.0, "low": 2.6, "date": "2016-12-20", "close": 2.7, "open": 2.6, "adj_high": 2.74, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 429396.0, "adj_low": 2.6, "adj_open": 2.6, "adj_close": 2.6, "high": 2.7, "adj_volume": 429396.0, "low": 2.6, "date": "2016-12-19", "close": 2.6, "open": 2.6, "adj_high": 2.7, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 498731.0, "adj_low": 2.6, "adj_open": 2.8, "adj_close": 2.65, "high": 2.825, "adj_volume": 498731.0, "low": 2.6, "date": "2016-12-16", "close": 2.65, "open": 2.8, "adj_high": 2.825, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 531181.0, "adj_low": 2.6, "adj_open": 2.75, "adj_close": 2.8, "high": 2.8, "adj_volume": 531181.0, "low": 2.6, "date": "2016-12-15", "close": 2.8, "open": 2.75, "adj_high": 2.8, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 373197.0, "adj_low": 2.65, "adj_open": 2.8, "adj_close": 2.7, "high": 2.85, "adj_volume": 373197.0, "low": 2.65, "date": "2016-12-14", "close": 2.7, "open": 2.8, "adj_high": 2.85, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 594106.0, "adj_low": 2.65, "adj_open": 3.0, "adj_close": 2.8, "high": 3.0, "adj_volume": 594106.0, "low": 2.65, "date": "2016-12-13", "close": 2.8, "open": 3.0, "adj_high": 3.0, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 463629.0, "adj_low": 2.9, "adj_open": 3.25, "adj_close": 2.95, "high": 3.25, "adj_volume": 463629.0, "low": 2.9, "date": "2016-12-12", "close": 2.95, "open": 3.25, "adj_high": 3.25, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 322612.0, "adj_low": 3.15, "adj_open": 3.15, "adj_close": 3.25, "high": 3.25, "adj_volume": 322612.0, "low": 3.15, "date": "2016-12-09", "close": 3.25, "open": 3.15, "adj_high": 3.25, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 134251.0, "adj_low": 3.15, "adj_open": 3.2, "adj_close": 3.15, "high": 3.2, "adj_volume": 134251.0, "low": 3.15, "date": "2016-12-08", "close": 3.15, "open": 3.2, "adj_high": 3.2, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 344489.0, "adj_low": 2.95, "adj_open": 3.1, "adj_close": 3.2, "high": 3.2, "adj_volume": 344489.0, "low": 2.95, "date": "2016-12-07", "close": 3.2, "open": 3.1, "adj_high": 3.2, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 273570.0, "adj_low": 2.9, "adj_open": 3.0, "adj_close": 3.05, "high": 3.05, "adj_volume": 273570.0, "low": 2.9, "date": "2016-12-06", "close": 3.05, "open": 3.0, "adj_high": 3.05, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 579468.0, "adj_low": 2.7, "adj_open": 2.7, "adj_close": 2.95, "high": 3.0, "adj_volume": 579468.0, "low": 2.7, "date": "2016-12-05", "close": 2.95, "open": 2.7, "adj_high": 3.0, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 173464.0, "adj_low": 2.6, "adj_open": 2.65, "adj_close": 2.675, "high": 2.7, "adj_volume": 173464.0, "low": 2.6, "date": "2016-12-02", "close": 2.675, "open": 2.65, "adj_high": 2.7, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 165966.0, "adj_low": 2.65, "adj_open": 2.7, "adj_close": 2.7, "high": 2.8, "adj_volume": 165966.0, "low": 2.65, "date": "2016-12-01", "close": 2.7, "open": 2.7, "adj_high": 2.8, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 735416.0, "adj_low": 2.65, "adj_open": 2.75, "adj_close": 2.65, "high": 3.05, "adj_volume": 735416.0, "low": 2.65, "date": "2016-11-30", "close": 2.65, "open": 2.75, "adj_high": 3.05, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 1939111.0, "adj_low": 2.55, "adj_open": 2.75, "adj_close": 2.65, "high": 2.75, "adj_volume": 1939111.0, "low": 2.55, "date": "2016-11-29", "close": 2.65, "open": 2.75, "adj_high": 2.75, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 298243.0, "adj_low": 2.6, "adj_open": 2.65, "adj_close": 2.7, "high": 2.75, "adj_volume": 298243.0, "low": 2.6, "date": "2016-11-28", "close": 2.7, "open": 2.65, "adj_high": 2.75, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 60216.0, "adj_low": 2.6, "adj_open": 2.65, "adj_close": 2.65, "high": 2.7, "adj_volume": 60216.0, "low": 2.6, "date": "2016-11-25", "close": 2.65, "open": 2.65, "adj_high": 2.7, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 124776.0, "adj_low": 2.6, "adj_open": 2.7, "adj_close": 2.7, "high": 2.7, "adj_volume": 124776.0, "low": 2.6, "date": "2016-11-23", "close": 2.7, "open": 2.7, "adj_high": 2.7, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 136535.0, "adj_low": 2.6, "adj_open": 2.75, "adj_close": 2.7, "high": 2.85, "adj_volume": 136535.0, "low": 2.6, "date": "2016-11-22", "close": 2.7, "open": 2.75, "adj_high": 2.85, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 472868.0, "adj_low": 2.45, "adj_open": 2.75, "adj_close": 2.7, "high": 2.75, "adj_volume": 472868.0, "low": 2.45, "date": "2016-11-21", "close": 2.7, "open": 2.75, "adj_high": 2.75, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 351966.0, "adj_low": 2.45, "adj_open": 2.8, "adj_close": 2.7, "high": 2.8, "adj_volume": 351966.0, "low": 2.45, "date": "2016-11-18", "close": 2.7, "open": 2.8, "adj_high": 2.8, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 212163.0, "adj_low": 2.625, "adj_open": 2.8, "adj_close": 2.75, "high": 2.85, "adj_volume": 212163.0, "low": 2.625, "date": "2016-11-17", "close": 2.75, "open": 2.8, "adj_high": 2.85, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 195584.0, "adj_low": 2.7, "adj_open": 2.8, "adj_close": 2.8, "high": 2.9, "adj_volume": 195584.0, "low": 2.7, "date": "2016-11-16", "close": 2.8, "open": 2.8, "adj_high": 2.9, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 184777.0, "adj_low": 2.75, "adj_open": 2.85, "adj_close": 2.8, "high": 2.9, "adj_volume": 184777.0, "low": 2.75, "date": "2016-11-15", "close": 2.8, "open": 2.85, "adj_high": 2.9, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 176845.0, "adj_low": 2.75, "adj_open": 2.95, "adj_close": 2.8, "high": 3.0, "adj_volume": 176845.0, "low": 2.75, "date": "2016-11-14", "close": 2.8, "open": 2.95, "adj_high": 3.0, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 271394.0, "adj_low": 2.65, "adj_open": 2.75, "adj_close": 2.8, "high": 2.85, "adj_volume": 271394.0, "low": 2.65, "date": "2016-11-11", "close": 2.8, "open": 2.75, "adj_high": 2.85, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 173068.0, "adj_low": 2.66, "adj_open": 2.85, "adj_close": 2.75, "high": 2.8857, "adj_volume": 173068.0, "low": 2.66, "date": "2016-11-10", "close": 2.75, "open": 2.85, "adj_high": 2.8857, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 235349.0, "adj_low": 2.75, "adj_open": 2.9, "adj_close": 2.8, "high": 3.15, "adj_volume": 235349.0, "low": 2.75, "date": "2016-11-09", "close": 2.8, "open": 2.9, "adj_high": 3.15, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 111344.0, "adj_low": 2.8, "adj_open": 2.95, "adj_close": 2.9, "high": 3.05, "adj_volume": 111344.0, "low": 2.8, "date": "2016-11-08", "close": 2.9, "open": 2.95, "adj_high": 3.05, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 74588.0, "adj_low": 2.9, "adj_open": 3.0, "adj_close": 2.95, "high": 3.1, "adj_volume": 74588.0, "low": 2.9, "date": "2016-11-07", "close": 2.95, "open": 3.0, "adj_high": 3.1, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 119046.0, "adj_low": 2.9, "adj_open": 2.95, "adj_close": 2.95, "high": 3.1, "adj_volume": 119046.0, "low": 2.9, "date": "2016-11-04", "close": 2.95, "open": 2.95, "adj_high": 3.1, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 67044.0, "adj_low": 2.95, "adj_open": 3.05, "adj_close": 3.05, "high": 3.1, "adj_volume": 67044.0, "low": 2.95, "date": "2016-11-03", "close": 3.05, "open": 3.05, "adj_high": 3.1, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 66728.0, "adj_low": 3.0, "adj_open": 3.05, "adj_close": 3.05, "high": 3.15, "adj_volume": 66728.0, "low": 3.0, "date": "2016-11-02", "close": 3.05, "open": 3.05, "adj_high": 3.15, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 89569.0, "adj_low": 3.0, "adj_open": 3.15, "adj_close": 3.1, "high": 3.2, "adj_volume": 89569.0, "low": 3.0, "date": "2016-11-01", "close": 3.1, "open": 3.15, "adj_high": 3.2, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 125333.0, "adj_low": 3.0, "adj_open": 3.2, "adj_close": 3.15, "high": 3.2, "adj_volume": 125333.0, "low": 3.0, "date": "2016-10-31", "close": 3.15, "open": 3.2, "adj_high": 3.2, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 73326.0, "adj_low": 3.1, "adj_open": 3.25, "adj_close": 3.15, "high": 3.25, "adj_volume": 73326.0, "low": 3.1, "date": "2016-10-28", "close": 3.15, "open": 3.25, "adj_high": 3.25, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 71872.0, "adj_low": 3.125, "adj_open": 3.2, "adj_close": 3.2, "high": 3.25, "adj_volume": 71872.0, "low": 3.125, "date": "2016-10-27", "close": 3.2, "open": 3.2, "adj_high": 3.25, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 48241.0, "adj_low": 3.1, "adj_open": 3.2, "adj_close": 3.175, "high": 3.2, "adj_volume": 48241.0, "low": 3.1, "date": "2016-10-26", "close": 3.175, "open": 3.2, "adj_high": 3.2, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 56050.0, "adj_low": 3.123, "adj_open": 3.15, "adj_close": 3.2, "high": 3.2, "adj_volume": 56050.0, "low": 3.123, "date": "2016-10-25", "close": 3.2, "open": 3.15, "adj_high": 3.2, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 120766.0, "adj_low": 3.1, "adj_open": 3.3, "adj_close": 3.1, "high": 3.3, "adj_volume": 120766.0, "low": 3.1, "date": "2016-10-24", "close": 3.1, "open": 3.3, "adj_high": 3.3, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 133211.0, "adj_low": 3.04, "adj_open": 3.05, "adj_close": 3.25, "high": 3.25, "adj_volume": 133211.0, "low": 3.04, "date": "2016-10-21", "close": 3.25, "open": 3.05, "adj_high": 3.25, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 182361.0, "adj_low": 2.96, "adj_open": 2.96, "adj_close": 3.08, "high": 3.12, "adj_volume": 182361.0, "low": 2.96, "date": "2016-10-20", "close": 3.08, "open": 2.96, "adj_high": 3.12, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 154500.0, "adj_low": 2.93, "adj_open": 2.99, "adj_close": 2.995, "high": 3.05, "adj_volume": 154500.0, "low": 2.93, "date": "2016-10-19", "close": 2.995, "open": 2.99, "adj_high": 3.05, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 65949.0, "adj_low": 2.9, "adj_open": 2.95, "adj_close": 2.98, "high": 2.99, "adj_volume": 65949.0, "low": 2.9, "date": "2016-10-18", "close": 2.98, "open": 2.95, "adj_high": 2.99, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 125963.0, "adj_low": 2.85, "adj_open": 2.87, "adj_close": 2.88, "high": 2.99, "adj_volume": 125963.0, "low": 2.85, "date": "2016-10-17", "close": 2.88, "open": 2.87, "adj_high": 2.99, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 215247.0, "adj_low": 2.81, "adj_open": 3.2, "adj_close": 2.87, "high": 3.2, "adj_volume": 215247.0, "low": 2.81, "date": "2016-10-14", "close": 2.87, "open": 3.2, "adj_high": 3.2, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 165521.0, "adj_low": 2.88, "adj_open": 3.0, "adj_close": 2.94, "high": 3.01, "adj_volume": 165521.0, "low": 2.88, "date": "2016-10-13", "close": 2.94, "open": 3.0, "adj_high": 3.01, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 160045.0, "adj_low": 3.02, "adj_open": 3.19, "adj_close": 3.03, "high": 3.22, "adj_volume": 160045.0, "low": 3.02, "date": "2016-10-12", "close": 3.03, "open": 3.19, "adj_high": 3.22, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 131317.0, "adj_low": 3.17, "adj_open": 3.36, "adj_close": 3.2, "high": 3.3732, "adj_volume": 131317.0, "low": 3.17, "date": "2016-10-11", "close": 3.2, "open": 3.36, "adj_high": 3.3732, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 25710.0, "adj_low": 3.33, "adj_open": 3.34, "adj_close": 3.36, "high": 3.4, "adj_volume": 25710.0, "low": 3.33, "date": "2016-10-10", "close": 3.36, "open": 3.34, "adj_high": 3.4, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 94934.0, "adj_low": 3.3, "adj_open": 3.39, "adj_close": 3.32, "high": 3.44, "adj_volume": 94934.0, "low": 3.3, "date": "2016-10-07", "close": 3.32, "open": 3.39, "adj_high": 3.44, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 184552.0, "adj_low": 3.38, "adj_open": 3.49, "adj_close": 3.4, "high": 3.5193, "adj_volume": 184552.0, "low": 3.38, "date": "2016-10-06", "close": 3.4, "open": 3.49, "adj_high": 3.5193, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 222315.0, "adj_low": 3.37, "adj_open": 3.37, "adj_close": 3.495, "high": 3.53, "adj_volume": 222315.0, "low": 3.37, "date": "2016-10-05", "close": 3.495, "open": 3.37, "adj_high": 3.53, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 103451.0, "adj_low": 3.36, "adj_open": 3.47, "adj_close": 3.37, "high": 3.49, "adj_volume": 103451.0, "low": 3.36, "date": "2016-10-04", "close": 3.37, "open": 3.47, "adj_high": 3.49, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 292558.0, "adj_low": 3.3, "adj_open": 3.56, "adj_close": 3.48, "high": 3.56, "adj_volume": 292558.0, "low": 3.3, "date": "2016-10-03", "close": 3.48, "open": 3.56, "adj_high": 3.56, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 860300.0, "adj_low": 3.3601, "adj_open": 3.75, "adj_close": 3.44, "high": 3.75, "adj_volume": 860300.0, "low": 3.3601, "date": "2016-09-30", "close": 3.44, "open": 3.75, "adj_high": 3.75, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 517548.0, "adj_low": 3.7801, "adj_open": 3.86, "adj_close": 3.89, "high": 4.0, "adj_volume": 517548.0, "low": 3.7801, "date": "2016-09-29", "close": 3.89, "open": 3.86, "adj_high": 4.0, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 68000.0, "adj_low": 3.8, "adj_open": 3.95, "adj_close": 3.8, "high": 3.95, "adj_volume": 68000.0, "low": 3.8, "date": "2016-09-28", "close": 3.8, "open": 3.95, "adj_high": 3.95, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 101301.0, "adj_low": 3.85, "adj_open": 3.98, "adj_close": 3.93, "high": 4.0, "adj_volume": 101301.0, "low": 3.85, "date": "2016-09-27", "close": 3.93, "open": 3.98, "adj_high": 4.0, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 183764.0, "adj_low": 3.9, "adj_open": 3.96, "adj_close": 3.99, "high": 4.01, "adj_volume": 183764.0, "low": 3.9, "date": "2016-09-26", "close": 3.99, "open": 3.96, "adj_high": 4.01, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 334963.0, "adj_low": 3.81, "adj_open": 3.92, "adj_close": 3.96, "high": 4.0, "adj_volume": 334963.0, "low": 3.81, "date": "2016-09-23", "close": 3.96, "open": 3.92, "adj_high": 4.0, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 131319.0, "adj_low": 3.87, "adj_open": 3.89, "adj_close": 3.95, "high": 4.0, "adj_volume": 131319.0, "low": 3.87, "date": "2016-09-22", "close": 3.95, "open": 3.89, "adj_high": 4.0, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 40289.0, "adj_low": 3.8201, "adj_open": 3.85, "adj_close": 3.89, "high": 3.89, "adj_volume": 40289.0, "low": 3.8201, "date": "2016-09-21", "close": 3.89, "open": 3.85, "adj_high": 3.89, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 97770.0, "adj_low": 3.7, "adj_open": 3.72, "adj_close": 3.84, "high": 3.84, "adj_volume": 97770.0, "low": 3.7, "date": "2016-09-20", "close": 3.84, "open": 3.72, "adj_high": 3.84, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 65237.0, "adj_low": 3.73, "adj_open": 3.78, "adj_close": 3.73, "high": 3.8, "adj_volume": 65237.0, "low": 3.73, "date": "2016-09-19", "close": 3.73, "open": 3.78, "adj_high": 3.8, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 52939.0, "adj_low": 3.65, "adj_open": 3.76, "adj_close": 3.78, "high": 3.83, "adj_volume": 52939.0, "low": 3.65, "date": "2016-09-16", "close": 3.78, "open": 3.76, "adj_high": 3.83, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 50432.0, "adj_low": 3.72, "adj_open": 3.76, "adj_close": 3.79, "high": 3.8, "adj_volume": 50432.0, "low": 3.72, "date": "2016-09-15", "close": 3.79, "open": 3.76, "adj_high": 3.8, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 80957.0, "adj_low": 3.6, "adj_open": 3.6, "adj_close": 3.75, "high": 3.8, "adj_volume": 80957.0, "low": 3.6, "date": "2016-09-14", "close": 3.75, "open": 3.6, "adj_high": 3.8, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 62834.0, "adj_low": 3.56, "adj_open": 3.7, "adj_close": 3.7, "high": 3.74, "adj_volume": 62834.0, "low": 3.56, "date": "2016-09-13", "close": 3.7, "open": 3.7, "adj_high": 3.74, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 68722.0, "adj_low": 3.6, "adj_open": 3.61, "adj_close": 3.74, "high": 3.76, "adj_volume": 68722.0, "low": 3.6, "date": "2016-09-12", "close": 3.74, "open": 3.61, "adj_high": 3.76, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 42035.0, "adj_low": 3.65, "adj_open": 3.7, "adj_close": 3.66, "high": 3.81, "adj_volume": 42035.0, "low": 3.65, "date": "2016-09-09", "close": 3.66, "open": 3.7, "adj_high": 3.81, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 47152.0, "adj_low": 3.67, "adj_open": 3.72, "adj_close": 3.745, "high": 3.79, "adj_volume": 47152.0, "low": 3.67, "date": "2016-09-08", "close": 3.745, "open": 3.72, "adj_high": 3.79, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 32775.0, "adj_low": 3.63, "adj_open": 3.67, "adj_close": 3.715, "high": 3.77, "adj_volume": 32775.0, "low": 3.63, "date": "2016-09-07", "close": 3.715, "open": 3.67, "adj_high": 3.77, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 191175.0, "adj_low": 3.59, "adj_open": 3.76, "adj_close": 3.71, "high": 3.83, "adj_volume": 191175.0, "low": 3.59, "date": "2016-09-06", "close": 3.71, "open": 3.76, "adj_high": 3.83, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 72673.0, "adj_low": 3.6973, "adj_open": 3.82, "adj_close": 3.76, "high": 3.84, "adj_volume": 72673.0, "low": 3.6973, "date": "2016-09-02", "close": 3.76, "open": 3.82, "adj_high": 3.84, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 44103.0, "adj_low": 3.72, "adj_open": 3.865, "adj_close": 3.79, "high": 3.865, "adj_volume": 44103.0, "low": 3.72, "date": "2016-09-01", "close": 3.79, "open": 3.865, "adj_high": 3.865, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 51290.0, "adj_low": 3.8, "adj_open": 3.9, "adj_close": 3.81, "high": 3.9, "adj_volume": 51290.0, "low": 3.8, "date": "2016-08-31", "close": 3.81, "open": 3.9, "adj_high": 3.9, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 49877.0, "adj_low": 3.82, "adj_open": 3.82, "adj_close": 3.8895, "high": 3.9, "adj_volume": 49877.0, "low": 3.82, "date": "2016-08-30", "close": 3.8895, "open": 3.82, "adj_high": 3.9, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 97422.0, "adj_low": 3.66, "adj_open": 3.74, "adj_close": 3.82, "high": 3.865, "adj_volume": 97422.0, "low": 3.66, "date": "2016-08-29", "close": 3.82, "open": 3.74, "adj_high": 3.865, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 44564.0, "adj_low": 3.62, "adj_open": 3.62, "adj_close": 3.69, "high": 3.79, "adj_volume": 44564.0, "low": 3.62, "date": "2016-08-26", "close": 3.69, "open": 3.62, "adj_high": 3.79, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 67863.0, "adj_low": 3.6, "adj_open": 3.81, "adj_close": 3.66, "high": 3.85, "adj_volume": 67863.0, "low": 3.6, "date": "2016-08-25", "close": 3.66, "open": 3.81, "adj_high": 3.85, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 114490.0, "adj_low": 3.75, "adj_open": 3.98, "adj_close": 3.79, "high": 4.0399, "adj_volume": 114490.0, "low": 3.75, "date": "2016-08-24", "close": 3.79, "open": 3.98, "adj_high": 4.0399, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 111603.0, "adj_low": 3.9, "adj_open": 3.9, "adj_close": 3.96, "high": 4.04, "adj_volume": 111603.0, "low": 3.9, "date": "2016-08-23", "close": 3.96, "open": 3.9, "adj_high": 4.04, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 93963.0, "adj_low": 3.651, "adj_open": 3.73, "adj_close": 3.94, "high": 3.97, "adj_volume": 93963.0, "low": 3.651, "date": "2016-08-22", "close": 3.94, "open": 3.73, "adj_high": 3.97, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 73248.0, "adj_low": 3.63, "adj_open": 3.79, "adj_close": 3.74, "high": 3.79, "adj_volume": 73248.0, "low": 3.63, "date": "2016-08-19", "close": 3.74, "open": 3.79, "adj_high": 3.79, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 63455.0, "adj_low": 3.61, "adj_open": 3.61, "adj_close": 3.72, "high": 3.78, "adj_volume": 63455.0, "low": 3.61, "date": "2016-08-18", "close": 3.72, "open": 3.61, "adj_high": 3.78, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 102123.0, "adj_low": 3.59, "adj_open": 3.7, "adj_close": 3.61, "high": 3.74, "adj_volume": 102123.0, "low": 3.59, "date": "2016-08-17", "close": 3.61, "open": 3.7, "adj_high": 3.74, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 46212.0, "adj_low": 3.74, "adj_open": 3.82, "adj_close": 3.75, "high": 3.84, "adj_volume": 46212.0, "low": 3.74, "date": "2016-08-16", "close": 3.75, "open": 3.82, "adj_high": 3.84, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 57379.0, "adj_low": 3.77, "adj_open": 3.77, "adj_close": 3.81, "high": 3.9, "adj_volume": 57379.0, "low": 3.77, "date": "2016-08-15", "close": 3.81, "open": 3.77, "adj_high": 3.9, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 95034.0, "adj_low": 3.61, "adj_open": 3.73, "adj_close": 3.8, "high": 3.84, "adj_volume": 95034.0, "low": 3.61, "date": "2016-08-12", "close": 3.8, "open": 3.73, "adj_high": 3.84, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 78709.0, "adj_low": 3.56, "adj_open": 3.6, "adj_close": 3.68, "high": 3.72, "adj_volume": 78709.0, "low": 3.56, "date": "2016-08-11", "close": 3.68, "open": 3.6, "adj_high": 3.72, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 142981.0, "adj_low": 3.535, "adj_open": 3.81, "adj_close": 3.62, "high": 3.85, "adj_volume": 142981.0, "low": 3.535, "date": "2016-08-10", "close": 3.62, "open": 3.81, "adj_high": 3.85, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 209988.0, "adj_low": 3.75, "adj_open": 3.8, "adj_close": 3.8, "high": 3.98, "adj_volume": 209988.0, "low": 3.75, "date": "2016-08-09", "close": 3.8, "open": 3.8, "adj_high": 3.98, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 137863.0, "adj_low": 3.9, "adj_open": 3.99, "adj_close": 3.94, "high": 4.1, "adj_volume": 137863.0, "low": 3.9, "date": "2016-08-08", "close": 3.94, "open": 3.99, "adj_high": 4.1, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 284475.0, "adj_low": 3.76, "adj_open": 3.95, "adj_close": 4.02, "high": 4.04, "adj_volume": 284475.0, "low": 3.76, "date": "2016-08-05", "close": 4.02, "open": 3.95, "adj_high": 4.04, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 96948.0, "adj_low": 4.3, "adj_open": 4.49, "adj_close": 4.37, "high": 4.49, "adj_volume": 96948.0, "low": 4.3, "date": "2016-08-04", "close": 4.37, "open": 4.49, "adj_high": 4.49, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 114016.0, "adj_low": 4.06, "adj_open": 4.06, "adj_close": 4.4, "high": 4.43, "adj_volume": 114016.0, "low": 4.06, "date": "2016-08-03", "close": 4.4, "open": 4.06, "adj_high": 4.43, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 97281.0, "adj_low": 4.06, "adj_open": 4.19, "adj_close": 4.1, "high": 4.24, "adj_volume": 97281.0, "low": 4.06, "date": "2016-08-02", "close": 4.1, "open": 4.19, "adj_high": 4.24, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 54817.0, "adj_low": 4.07, "adj_open": 4.09, "adj_close": 4.17, "high": 4.26, "adj_volume": 54817.0, "low": 4.07, "date": "2016-08-01", "close": 4.17, "open": 4.09, "adj_high": 4.26, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 101606.0, "adj_low": 4.055, "adj_open": 4.09, "adj_close": 4.09, "high": 4.2, "adj_volume": 101606.0, "low": 4.055, "date": "2016-07-29", "close": 4.09, "open": 4.09, "adj_high": 4.2, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 70687.0, "adj_low": 4.07, "adj_open": 4.23, "adj_close": 4.13, "high": 4.23, "adj_volume": 70687.0, "low": 4.07, "date": "2016-07-28", "close": 4.13, "open": 4.23, "adj_high": 4.23, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 64042.0, "adj_low": 4.13, "adj_open": 4.14, "adj_close": 4.24, "high": 4.24, "adj_volume": 64042.0, "low": 4.13, "date": "2016-07-27", "close": 4.24, "open": 4.14, "adj_high": 4.24, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 87635.0, "adj_low": 4.05, "adj_open": 4.18, "adj_close": 4.1, "high": 4.2, "adj_volume": 87635.0, "low": 4.05, "date": "2016-07-26", "close": 4.1, "open": 4.18, "adj_high": 4.2, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 104332.0, "adj_low": 4.12, "adj_open": 4.25, "adj_close": 4.21, "high": 4.26, "adj_volume": 104332.0, "low": 4.12, "date": "2016-07-25", "close": 4.21, "open": 4.25, "adj_high": 4.26, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 127684.0, "adj_low": 4.08, "adj_open": 4.21, "adj_close": 4.2, "high": 4.23, "adj_volume": 127684.0, "low": 4.08, "date": "2016-07-22", "close": 4.2, "open": 4.21, "adj_high": 4.23, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 55861.0, "adj_low": 4.14, "adj_open": 4.21, "adj_close": 4.21, "high": 4.279, "adj_volume": 55861.0, "low": 4.14, "date": "2016-07-21", "close": 4.21, "open": 4.21, "adj_high": 4.279, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 204573.0, "adj_low": 4.14, "adj_open": 4.15, "adj_close": 4.18, "high": 4.3, "adj_volume": 204573.0, "low": 4.14, "date": "2016-07-20", "close": 4.18, "open": 4.15, "adj_high": 4.3, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 63997.0, "adj_low": 4.05, "adj_open": 4.14, "adj_close": 4.07, "high": 4.25, "adj_volume": 63997.0, "low": 4.05, "date": "2016-07-19", "close": 4.07, "open": 4.14, "adj_high": 4.25, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 85319.0, "adj_low": 4.15, "adj_open": 4.16, "adj_close": 4.2, "high": 4.25, "adj_volume": 85319.0, "low": 4.15, "date": "2016-07-18", "close": 4.2, "open": 4.16, "adj_high": 4.25, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 87248.0, "adj_low": 4.05, "adj_open": 4.05, "adj_close": 4.21, "high": 4.25, "adj_volume": 87248.0, "low": 4.05, "date": "2016-07-15", "close": 4.21, "open": 4.05, "adj_high": 4.25, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 110243.0, "adj_low": 3.99, "adj_open": 4.07, "adj_close": 4.05, "high": 4.15, "adj_volume": 110243.0, "low": 3.99, "date": "2016-07-14", "close": 4.05, "open": 4.07, "adj_high": 4.15, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 76884.0, "adj_low": 4.01, "adj_open": 4.13, "adj_close": 4.06, "high": 4.25, "adj_volume": 76884.0, "low": 4.01, "date": "2016-07-13", "close": 4.06, "open": 4.13, "adj_high": 4.25, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 107183.0, "adj_low": 3.916, "adj_open": 4.05, "adj_close": 4.15, "high": 4.21, "adj_volume": 107183.0, "low": 3.916, "date": "2016-07-12", "close": 4.15, "open": 4.05, "adj_high": 4.21, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 136466.0, "adj_low": 3.91, "adj_open": 3.95, "adj_close": 3.99, "high": 4.04, "adj_volume": 136466.0, "low": 3.91, "date": "2016-07-11", "close": 3.99, "open": 3.95, "adj_high": 4.04, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 283784.0, "adj_low": 3.71, "adj_open": 3.71, "adj_close": 3.91, "high": 3.98, "adj_volume": 283784.0, "low": 3.71, "date": "2016-07-08", "close": 3.91, "open": 3.71, "adj_high": 3.98, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 137269.0, "adj_low": 3.85, "adj_open": 3.89, "adj_close": 3.99, "high": 4.05, "adj_volume": 137269.0, "low": 3.85, "date": "2016-07-07", "close": 3.99, "open": 3.89, "adj_high": 4.05, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 173643.0, "adj_low": 3.72, "adj_open": 3.78, "adj_close": 3.85, "high": 3.9099, "adj_volume": 173643.0, "low": 3.72, "date": "2016-07-06", "close": 3.85, "open": 3.78, "adj_high": 3.9099, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 186585.0, "adj_low": 3.64, "adj_open": 3.75, "adj_close": 3.78, "high": 3.83, "adj_volume": 186585.0, "low": 3.64, "date": "2016-07-05", "close": 3.78, "open": 3.75, "adj_high": 3.83, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 272750.0, "adj_low": 3.4001, "adj_open": 3.45, "adj_close": 3.77, "high": 3.82, "adj_volume": 272750.0, "low": 3.4001, "date": "2016-07-01", "close": 3.77, "open": 3.45, "adj_high": 3.82, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 300842.0, "adj_low": 3.45, "adj_open": 3.54, "adj_close": 3.48, "high": 3.65, "adj_volume": 300842.0, "low": 3.45, "date": "2016-06-30", "close": 3.48, "open": 3.54, "adj_high": 3.65, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 334536.0, "adj_low": 3.37, "adj_open": 3.42, "adj_close": 3.51, "high": 3.58, "adj_volume": 334536.0, "low": 3.37, "date": "2016-06-29", "close": 3.51, "open": 3.42, "adj_high": 3.58, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 179351.0, "adj_low": 3.35, "adj_open": 3.38, "adj_close": 3.37, "high": 3.5, "adj_volume": 179351.0, "low": 3.35, "date": "2016-06-28", "close": 3.37, "open": 3.38, "adj_high": 3.5, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 180197.0, "adj_low": 3.17, "adj_open": 3.36, "adj_close": 3.34, "high": 3.49, "adj_volume": 180197.0, "low": 3.17, "date": "2016-06-27", "close": 3.34, "open": 3.36, "adj_high": 3.49, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 244167.0, "adj_low": 3.3, "adj_open": 3.37, "adj_close": 3.36, "high": 3.61, "adj_volume": 244167.0, "low": 3.3, "date": "2016-06-24", "close": 3.36, "open": 3.37, "adj_high": 3.61, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 204465.0, "adj_low": 3.3143, "adj_open": 3.36, "adj_close": 3.54, "high": 3.59, "adj_volume": 204465.0, "low": 3.3143, "date": "2016-06-23", "close": 3.54, "open": 3.36, "adj_high": 3.59, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 181466.0, "adj_low": 3.09, "adj_open": 3.15, "adj_close": 3.32, "high": 3.32, "adj_volume": 181466.0, "low": 3.09, "date": "2016-06-22", "close": 3.32, "open": 3.15, "adj_high": 3.32, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 266336.0, "adj_low": 3.15, "adj_open": 3.26, "adj_close": 3.17, "high": 3.29, "adj_volume": 266336.0, "low": 3.15, "date": "2016-06-21", "close": 3.17, "open": 3.26, "adj_high": 3.29, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 160830.0, "adj_low": 3.23, "adj_open": 3.31, "adj_close": 3.26, "high": 3.34, "adj_volume": 160830.0, "low": 3.23, "date": "2016-06-20", "close": 3.26, "open": 3.31, "adj_high": 3.34, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 135994.0, "adj_low": 3.19, "adj_open": 3.3, "adj_close": 3.3, "high": 3.34, "adj_volume": 135994.0, "low": 3.19, "date": "2016-06-17", "close": 3.3, "open": 3.3, "adj_high": 3.34, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 165097.0, "adj_low": 3.15, "adj_open": 3.26, "adj_close": 3.28, "high": 3.37, "adj_volume": 165097.0, "low": 3.15, "date": "2016-06-16", "close": 3.28, "open": 3.26, "adj_high": 3.37, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 307733.0, "adj_low": 3.12, "adj_open": 3.25, "adj_close": 3.22, "high": 3.39, "adj_volume": 307733.0, "low": 3.12, "date": "2016-06-15", "close": 3.22, "open": 3.25, "adj_high": 3.39, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 232464.0, "adj_low": 3.21, "adj_open": 3.39, "adj_close": 3.29, "high": 3.4, "adj_volume": 232464.0, "low": 3.21, "date": "2016-06-14", "close": 3.29, "open": 3.39, "adj_high": 3.4, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 529182.0, "adj_low": 3.17, "adj_open": 3.5, "adj_close": 3.36, "high": 3.5301, "adj_volume": 529182.0, "low": 3.17, "date": "2016-06-13", "close": 3.36, "open": 3.5, "adj_high": 3.5301, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 287981.0, "adj_low": 3.55, "adj_open": 3.87, "adj_close": 3.6, "high": 3.91, "adj_volume": 287981.0, "low": 3.55, "date": "2016-06-10", "close": 3.6, "open": 3.87, "adj_high": 3.91, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 114263.0, "adj_low": 3.87, "adj_open": 4.02, "adj_close": 3.93, "high": 4.03, "adj_volume": 114263.0, "low": 3.87, "date": "2016-06-09", "close": 3.93, "open": 4.02, "adj_high": 4.03, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 232921.0, "adj_low": 3.96, "adj_open": 4.04, "adj_close": 4.02, "high": 4.14, "adj_volume": 232921.0, "low": 3.96, "date": "2016-06-08", "close": 4.02, "open": 4.04, "adj_high": 4.14, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 174651.0, "adj_low": 4.03, "adj_open": 4.11, "adj_close": 4.07, "high": 4.15, "adj_volume": 174651.0, "low": 4.03, "date": "2016-06-07", "close": 4.07, "open": 4.11, "adj_high": 4.15, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 172196.0, "adj_low": 3.86, "adj_open": 3.93, "adj_close": 4.14, "high": 4.15, "adj_volume": 172196.0, "low": 3.86, "date": "2016-06-06", "close": 4.14, "open": 3.93, "adj_high": 4.15, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 156002.0, "adj_low": 3.85, "adj_open": 4.01, "adj_close": 3.95, "high": 4.1, "adj_volume": 156002.0, "low": 3.85, "date": "2016-06-03", "close": 3.95, "open": 4.01, "adj_high": 4.1, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 156802.0, "adj_low": 3.94, "adj_open": 3.99, "adj_close": 3.99, "high": 4.1, "adj_volume": 156802.0, "low": 3.94, "date": "2016-06-02", "close": 3.99, "open": 3.99, "adj_high": 4.1, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 104782.0, "adj_low": 3.87, "adj_open": 4.13, "adj_close": 3.97, "high": 4.13, "adj_volume": 104782.0, "low": 3.87, "date": "2016-06-01", "close": 3.97, "open": 4.13, "adj_high": 4.13, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 108893.0, "adj_low": 4.04, "adj_open": 4.15, "adj_close": 4.14, "high": 4.2, "adj_volume": 108893.0, "low": 4.04, "date": "2016-05-31", "close": 4.14, "open": 4.15, "adj_high": 4.2, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 68004.0, "adj_low": 4.07, "adj_open": 4.25, "adj_close": 4.1, "high": 4.3, "adj_volume": 68004.0, "low": 4.07, "date": "2016-05-27", "close": 4.1, "open": 4.25, "adj_high": 4.3, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 104496.0, "adj_low": 4.135, "adj_open": 4.25, "adj_close": 4.26, "high": 4.27, "adj_volume": 104496.0, "low": 4.135, "date": "2016-05-26", "close": 4.26, "open": 4.25, "adj_high": 4.27, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 152888.0, "adj_low": 4.05, "adj_open": 4.1, "adj_close": 4.2, "high": 4.33, "adj_volume": 152888.0, "low": 4.05, "date": "2016-05-25", "close": 4.2, "open": 4.1, "adj_high": 4.33, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 113007.0, "adj_low": 3.97, "adj_open": 4.02, "adj_close": 4.06, "high": 4.14, "adj_volume": 113007.0, "low": 3.97, "date": "2016-05-24", "close": 4.06, "open": 4.02, "adj_high": 4.14, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 89687.0, "adj_low": 3.98, "adj_open": 4.08, "adj_close": 4.03, "high": 4.17, "adj_volume": 89687.0, "low": 3.98, "date": "2016-05-23", "close": 4.03, "open": 4.08, "adj_high": 4.17, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 75324.0, "adj_low": 3.91, "adj_open": 3.91, "adj_close": 4.08, "high": 4.09, "adj_volume": 75324.0, "low": 3.91, "date": "2016-05-20", "close": 4.08, "open": 3.91, "adj_high": 4.09, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 80302.0, "adj_low": 3.82, "adj_open": 4.0, "adj_close": 3.89, "high": 4.06, "adj_volume": 80302.0, "low": 3.82, "date": "2016-05-19", "close": 3.89, "open": 4.0, "adj_high": 4.06, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 155407.0, "adj_low": 3.9, "adj_open": 3.9, "adj_close": 4.01, "high": 4.06, "adj_volume": 155407.0, "low": 3.9, "date": "2016-05-18", "close": 4.01, "open": 3.9, "adj_high": 4.06, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 110956.0, "adj_low": 3.9, "adj_open": 4.15, "adj_close": 3.92, "high": 4.15, "adj_volume": 110956.0, "low": 3.9, "date": "2016-05-17", "close": 3.92, "open": 4.15, "adj_high": 4.15, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 287067.0, "adj_low": 3.9, "adj_open": 4.15, "adj_close": 4.16, "high": 4.3, "adj_volume": 287067.0, "low": 3.9, "date": "2016-05-16", "close": 4.16, "open": 4.15, "adj_high": 4.3, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 64503.0, "adj_low": 4.12, "adj_open": 4.19, "adj_close": 4.35, "high": 4.42, "adj_volume": 64503.0, "low": 4.12, "date": "2016-05-13", "close": 4.35, "open": 4.19, "adj_high": 4.42, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 117555.0, "adj_low": 4.19, "adj_open": 4.32, "adj_close": 4.19, "high": 4.33, "adj_volume": 117555.0, "low": 4.19, "date": "2016-05-12", "close": 4.19, "open": 4.32, "adj_high": 4.33, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 65118.0, "adj_low": 4.28, "adj_open": 4.5, "adj_close": 4.31, "high": 4.58, "adj_volume": 65118.0, "low": 4.28, "date": "2016-05-11", "close": 4.31, "open": 4.5, "adj_high": 4.58, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 138224.0, "adj_low": 4.22, "adj_open": 4.34, "adj_close": 4.5, "high": 4.5, "adj_volume": 138224.0, "low": 4.22, "date": "2016-05-10", "close": 4.5, "open": 4.34, "adj_high": 4.5, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 142855.0, "adj_low": 4.05, "adj_open": 4.05, "adj_close": 4.29, "high": 4.44, "adj_volume": 142855.0, "low": 4.05, "date": "2016-05-09", "close": 4.29, "open": 4.05, "adj_high": 4.44, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 133884.0, "adj_low": 4.1, "adj_open": 4.46, "adj_close": 4.15, "high": 4.57, "adj_volume": 133884.0, "low": 4.1, "date": "2016-05-06", "close": 4.15, "open": 4.46, "adj_high": 4.57, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 240533.0, "adj_low": 4.05, "adj_open": 4.1, "adj_close": 4.51, "high": 4.62, "adj_volume": 240533.0, "low": 4.05, "date": "2016-05-05", "close": 4.51, "open": 4.1, "adj_high": 4.62, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 139832.0, "adj_low": 4.58, "adj_open": 4.88, "adj_close": 4.64, "high": 4.88, "adj_volume": 139832.0, "low": 4.58, "date": "2016-05-04", "close": 4.64, "open": 4.88, "adj_high": 4.88, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 140808.0, "adj_low": 4.65, "adj_open": 4.75, "adj_close": 4.69, "high": 4.9, "adj_volume": 140808.0, "low": 4.65, "date": "2016-05-03", "close": 4.69, "open": 4.75, "adj_high": 4.9, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 83872.0, "adj_low": 4.71, "adj_open": 4.96, "adj_close": 4.82, "high": 4.96, "adj_volume": 83872.0, "low": 4.71, "date": "2016-05-02", "close": 4.82, "open": 4.96, "adj_high": 4.96, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 233783.0, "adj_low": 4.8, "adj_open": 5.15, "adj_close": 4.95, "high": 5.1634, "adj_volume": 233783.0, "low": 4.8, "date": "2016-04-29", "close": 4.95, "open": 5.15, "adj_high": 5.1634, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 113124.0, "adj_low": 5.1005, "adj_open": 5.2, "adj_close": 5.17, "high": 5.3, "adj_volume": 113124.0, "low": 5.1005, "date": "2016-04-28", "close": 5.17, "open": 5.2, "adj_high": 5.3, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 100377.0, "adj_low": 5.1, "adj_open": 5.3, "adj_close": 5.2, "high": 5.3399, "adj_volume": 100377.0, "low": 5.1, "date": "2016-04-27", "close": 5.2, "open": 5.3, "adj_high": 5.3399, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 119840.0, "adj_low": 5.1, "adj_open": 5.3, "adj_close": 5.27, "high": 5.37, "adj_volume": 119840.0, "low": 5.1, "date": "2016-04-26", "close": 5.27, "open": 5.3, "adj_high": 5.37, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 209460.0, "adj_low": 5.25, "adj_open": 5.44, "adj_close": 5.29, "high": 5.48, "adj_volume": 209460.0, "low": 5.25, "date": "2016-04-25", "close": 5.29, "open": 5.44, "adj_high": 5.48, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 369598.0, "adj_low": 5.0, "adj_open": 5.02, "adj_close": 5.33, "high": 5.4797, "adj_volume": 369598.0, "low": 5.0, "date": "2016-04-22", "close": 5.33, "open": 5.02, "adj_high": 5.4797, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 114120.0, "adj_low": 4.94, "adj_open": 4.95, "adj_close": 5.05, "high": 5.1, "adj_volume": 114120.0, "low": 4.94, "date": "2016-04-21", "close": 5.05, "open": 4.95, "adj_high": 5.1, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 75506.0, "adj_low": 4.8252, "adj_open": 4.91, "adj_close": 4.96, "high": 4.99, "adj_volume": 75506.0, "low": 4.8252, "date": "2016-04-20", "close": 4.96, "open": 4.91, "adj_high": 4.99, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 113445.0, "adj_low": 4.85, "adj_open": 5.02, "adj_close": 4.9, "high": 5.052, "adj_volume": 113445.0, "low": 4.85, "date": "2016-04-19", "close": 4.9, "open": 5.02, "adj_high": 5.052, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 147692.0, "adj_low": 4.7486, "adj_open": 4.76, "adj_close": 4.98, "high": 5.13, "adj_volume": 147692.0, "low": 4.7486, "date": "2016-04-18", "close": 4.98, "open": 4.76, "adj_high": 5.13, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 110804.0, "adj_low": 4.7, "adj_open": 4.96, "adj_close": 4.85, "high": 4.96, "adj_volume": 110804.0, "low": 4.7, "date": "2016-04-15", "close": 4.85, "open": 4.96, "adj_high": 4.96, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 198060.0, "adj_low": 4.84, "adj_open": 5.1, "adj_close": 4.94, "high": 5.17, "adj_volume": 198060.0, "low": 4.84, "date": "2016-04-14", "close": 4.94, "open": 5.1, "adj_high": 5.17, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 161491.0, "adj_low": 4.84, "adj_open": 5.19, "adj_close": 5.09, "high": 5.19, "adj_volume": 161491.0, "low": 4.84, "date": "2016-04-13", "close": 5.09, "open": 5.19, "adj_high": 5.19, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 260011.0, "adj_low": 4.66, "adj_open": 4.74, "adj_close": 4.92, "high": 5.02, "adj_volume": 260011.0, "low": 4.66, "date": "2016-04-12", "close": 4.92, "open": 4.74, "adj_high": 5.02, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 358066.0, "adj_low": 4.53, "adj_open": 5.11, "adj_close": 4.72, "high": 5.2299, "adj_volume": 358066.0, "low": 4.53, "date": "2016-04-11", "close": 4.72, "open": 5.11, "adj_high": 5.2299, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 917678.0, "adj_low": 4.79, "adj_open": 5.13, "adj_close": 5.05, "high": 5.45, "adj_volume": 917678.0, "low": 4.79, "date": "2016-04-08", "close": 5.05, "open": 5.13, "adj_high": 5.45, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 445717.0, "adj_low": 4.5, "adj_open": 4.75, "adj_close": 5.06, "high": 5.14, "adj_volume": 445717.0, "low": 4.5, "date": "2016-04-07", "close": 5.06, "open": 4.75, "adj_high": 5.14, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 288830.0, "adj_low": 4.35, "adj_open": 4.39, "adj_close": 4.7, "high": 4.72, "adj_volume": 288830.0, "low": 4.35, "date": "2016-04-06", "close": 4.7, "open": 4.39, "adj_high": 4.72, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 152124.0, "adj_low": 4.07, "adj_open": 4.1, "adj_close": 4.35, "high": 4.4, "adj_volume": 152124.0, "low": 4.07, "date": "2016-04-05", "close": 4.35, "open": 4.1, "adj_high": 4.4, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 168930.0, "adj_low": 4.035, "adj_open": 4.11, "adj_close": 4.15, "high": 4.28, "adj_volume": 168930.0, "low": 4.035, "date": "2016-04-04", "close": 4.15, "open": 4.11, "adj_high": 4.28, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 140704.0, "adj_low": 4.04, "adj_open": 4.09, "adj_close": 4.17, "high": 4.28, "adj_volume": 140704.0, "low": 4.04, "date": "2016-04-01", "close": 4.17, "open": 4.09, "adj_high": 4.28, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 141067.0, "adj_low": 3.98, "adj_open": 3.98, "adj_close": 4.13, "high": 4.185, "adj_volume": 141067.0, "low": 3.98, "date": "2016-03-31", "close": 4.13, "open": 3.98, "adj_high": 4.185, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 123034.0, "adj_low": 3.85, "adj_open": 4.15, "adj_close": 3.94, "high": 4.22, "adj_volume": 123034.0, "low": 3.85, "date": "2016-03-30", "close": 3.94, "open": 4.15, "adj_high": 4.22, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 123527.0, "adj_low": 3.64, "adj_open": 3.81, "adj_close": 4.09, "high": 4.18, "adj_volume": 123527.0, "low": 3.64, "date": "2016-03-29", "close": 4.09, "open": 3.81, "adj_high": 4.18, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 135914.0, "adj_low": 3.73, "adj_open": 4.0, "adj_close": 3.81, "high": 4.0, "adj_volume": 135914.0, "low": 3.73, "date": "2016-03-28", "close": 3.81, "open": 4.0, "adj_high": 4.0, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 104614.0, "adj_low": 3.7101, "adj_open": 3.88, "adj_close": 3.99, "high": 4.065, "adj_volume": 104614.0, "low": 3.7101, "date": "2016-03-24", "close": 3.99, "open": 3.88, "adj_high": 4.065, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 242307.0, "adj_low": 3.82, "adj_open": 4.3, "adj_close": 3.89, "high": 4.31, "adj_volume": 242307.0, "low": 3.82, "date": "2016-03-23", "close": 3.89, "open": 4.3, "adj_high": 4.31, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 196801.0, "adj_low": 4.11, "adj_open": 4.15, "adj_close": 4.34, "high": 4.4, "adj_volume": 196801.0, "low": 4.11, "date": "2016-03-22", "close": 4.34, "open": 4.15, "adj_high": 4.4, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 263407.0, "adj_low": 3.98, "adj_open": 3.98, "adj_close": 4.13, "high": 4.3, "adj_volume": 263407.0, "low": 3.98, "date": "2016-03-21", "close": 4.13, "open": 3.98, "adj_high": 4.3, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 114147.0, "adj_low": 3.5825, "adj_open": 3.64, "adj_close": 3.96, "high": 3.98, "adj_volume": 114147.0, "low": 3.5825, "date": "2016-03-18", "close": 3.96, "open": 3.64, "adj_high": 3.98, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 131896.0, "adj_low": 3.5, "adj_open": 3.73, "adj_close": 3.64, "high": 3.75, "adj_volume": 131896.0, "low": 3.5, "date": "2016-03-17", "close": 3.64, "open": 3.73, "adj_high": 3.75, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 123405.0, "adj_low": 3.57, "adj_open": 3.7, "adj_close": 3.69, "high": 3.74, "adj_volume": 123405.0, "low": 3.57, "date": "2016-03-16", "close": 3.69, "open": 3.7, "adj_high": 3.74, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 201764.0, "adj_low": 3.6, "adj_open": 3.97, "adj_close": 3.69, "high": 3.97, "adj_volume": 201764.0, "low": 3.6, "date": "2016-03-15", "close": 3.69, "open": 3.97, "adj_high": 3.97, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 156275.0, "adj_low": 3.7666, "adj_open": 3.86, "adj_close": 3.94, "high": 3.98, "adj_volume": 156275.0, "low": 3.7666, "date": "2016-03-14", "close": 3.94, "open": 3.86, "adj_high": 3.98, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 118926.0, "adj_low": 3.7, "adj_open": 3.79, "adj_close": 3.85, "high": 3.9115, "adj_volume": 118926.0, "low": 3.7, "date": "2016-03-11", "close": 3.85, "open": 3.79, "adj_high": 3.9115, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 124083.0, "adj_low": 3.71, "adj_open": 3.9, "adj_close": 3.74, "high": 3.97, "adj_volume": 124083.0, "low": 3.71, "date": "2016-03-10", "close": 3.74, "open": 3.9, "adj_high": 3.97, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 214250.0, "adj_low": 3.73, "adj_open": 3.97, "adj_close": 3.88, "high": 3.98, "adj_volume": 214250.0, "low": 3.73, "date": "2016-03-09", "close": 3.88, "open": 3.97, "adj_high": 3.98, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 151431.0, "adj_low": 3.92, "adj_open": 3.98, "adj_close": 3.96, "high": 4.17, "adj_volume": 151431.0, "low": 3.92, "date": "2016-03-08", "close": 3.96, "open": 3.98, "adj_high": 4.17, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 360555.0, "adj_low": 3.99, "adj_open": 4.0, "adj_close": 4.01, "high": 4.3, "adj_volume": 360555.0, "low": 3.99, "date": "2016-03-07", "close": 4.01, "open": 4.0, "adj_high": 4.3, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 363657.0, "adj_low": 3.5, "adj_open": 3.59, "adj_close": 3.91, "high": 4.0, "adj_volume": 363657.0, "low": 3.5, "date": "2016-03-04", "close": 3.91, "open": 3.59, "adj_high": 4.0, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 104141.0, "adj_low": 3.57, "adj_open": 3.67, "adj_close": 3.59, "high": 3.68, "adj_volume": 104141.0, "low": 3.57, "date": "2016-03-03", "close": 3.59, "open": 3.67, "adj_high": 3.68, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 392654.0, "adj_low": 3.14, "adj_open": 3.16, "adj_close": 3.6, "high": 3.61, "adj_volume": 392654.0, "low": 3.14, "date": "2016-03-02", "close": 3.6, "open": 3.16, "adj_high": 3.61, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 220463.0, "adj_low": 3.1, "adj_open": 3.18, "adj_close": 3.15, "high": 3.24, "adj_volume": 220463.0, "low": 3.1, "date": "2016-03-01", "close": 3.15, "open": 3.18, "adj_high": 3.24, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 151328.0, "adj_low": 3.11, "adj_open": 3.16, "adj_close": 3.16, "high": 3.22, "adj_volume": 151328.0, "low": 3.11, "date": "2016-02-29", "close": 3.16, "open": 3.16, "adj_high": 3.22, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 226408.0, "adj_low": 2.97, "adj_open": 3.0, "adj_close": 3.09, "high": 3.22, "adj_volume": 226408.0, "low": 2.97, "date": "2016-02-26", "close": 3.09, "open": 3.0, "adj_high": 3.22, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 63075.0, "adj_low": 2.97, "adj_open": 3.1, "adj_close": 2.99, "high": 3.13, "adj_volume": 63075.0, "low": 2.97, "date": "2016-02-25", "close": 2.99, "open": 3.1, "adj_high": 3.13, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 157490.0, "adj_low": 2.99, "adj_open": 3.15, "adj_close": 3.08, "high": 3.19, "adj_volume": 157490.0, "low": 2.99, "date": "2016-02-24", "close": 3.08, "open": 3.15, "adj_high": 3.19, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 115597.0, "adj_low": 3.12, "adj_open": 3.22, "adj_close": 3.17, "high": 3.29, "adj_volume": 115597.0, "low": 3.12, "date": "2016-02-23", "close": 3.17, "open": 3.22, "adj_high": 3.29, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 165665.0, "adj_low": 3.1328, "adj_open": 3.2, "adj_close": 3.21, "high": 3.29, "adj_volume": 165665.0, "low": 3.1328, "date": "2016-02-22", "close": 3.21, "open": 3.2, "adj_high": 3.29, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 171293.0, "adj_low": 3.06, "adj_open": 3.1, "adj_close": 3.13, "high": 3.22, "adj_volume": 171293.0, "low": 3.06, "date": "2016-02-19", "close": 3.13, "open": 3.1, "adj_high": 3.22, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 81895.0, "adj_low": 3.05, "adj_open": 3.14, "adj_close": 3.11, "high": 3.19, "adj_volume": 81895.0, "low": 3.05, "date": "2016-02-18", "close": 3.11, "open": 3.14, "adj_high": 3.19, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 330152.0, "adj_low": 3.01, "adj_open": 3.13, "adj_close": 3.15, "high": 3.18, "adj_volume": 330152.0, "low": 3.01, "date": "2016-02-17", "close": 3.15, "open": 3.13, "adj_high": 3.18, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 143347.0, "adj_low": 2.92, "adj_open": 3.01, "adj_close": 3.07, "high": 3.1299, "adj_volume": 143347.0, "low": 2.92, "date": "2016-02-16", "close": 3.07, "open": 3.01, "adj_high": 3.1299, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 126688.0, "adj_low": 2.8951, "adj_open": 3.0, "adj_close": 3.0, "high": 3.03, "adj_volume": 126688.0, "low": 2.8951, "date": "2016-02-12", "close": 3.0, "open": 3.0, "adj_high": 3.03, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 222859.0, "adj_low": 2.8, "adj_open": 2.88, "adj_close": 2.95, "high": 2.99, "adj_volume": 222859.0, "low": 2.8, "date": "2016-02-11", "close": 2.95, "open": 2.88, "adj_high": 2.99, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 269526.0, "adj_low": 2.84, "adj_open": 3.02, "adj_close": 2.89, "high": 3.07, "adj_volume": 269526.0, "low": 2.84, "date": "2016-02-10", "close": 2.89, "open": 3.02, "adj_high": 3.07, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 315476.0, "adj_low": 2.72, "adj_open": 2.85, "adj_close": 3.0, "high": 3.04, "adj_volume": 315476.0, "low": 2.72, "date": "2016-02-09", "close": 3.0, "open": 2.85, "adj_high": 3.04, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 293884.0, "adj_low": 2.86, "adj_open": 3.12, "adj_close": 2.9, "high": 3.269, "adj_volume": 293884.0, "low": 2.86, "date": "2016-02-08", "close": 2.9, "open": 3.12, "adj_high": 3.269, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 186560.0, "adj_low": 3.06, "adj_open": 3.17, "adj_close": 3.13, "high": 3.21, "adj_volume": 186560.0, "low": 3.06, "date": "2016-02-05", "close": 3.13, "open": 3.17, "adj_high": 3.21, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 193837.0, "adj_low": 3.05, "adj_open": 3.15, "adj_close": 3.17, "high": 3.23, "adj_volume": 193837.0, "low": 3.05, "date": "2016-02-04", "close": 3.17, "open": 3.15, "adj_high": 3.23, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 153991.0, "adj_low": 2.96, "adj_open": 3.11, "adj_close": 3.12, "high": 3.2199, "adj_volume": 153991.0, "low": 2.96, "date": "2016-02-03", "close": 3.12, "open": 3.11, "adj_high": 3.2199, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 183384.0, "adj_low": 3.0201, "adj_open": 3.1, "adj_close": 3.08, "high": 3.23, "adj_volume": 183384.0, "low": 3.0201, "date": "2016-02-02", "close": 3.08, "open": 3.1, "adj_high": 3.23, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 351271.0, "adj_low": 2.98, "adj_open": 3.15, "adj_close": 3.13, "high": 3.29, "adj_volume": 351271.0, "low": 2.98, "date": "2016-02-01", "close": 3.13, "open": 3.15, "adj_high": 3.29, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 443567.0, "adj_low": 3.12, "adj_open": 3.25, "adj_close": 3.14, "high": 3.43, "adj_volume": 443567.0, "low": 3.12, "date": "2016-01-29", "close": 3.14, "open": 3.25, "adj_high": 3.43, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 407470.0, "adj_low": 3.192, "adj_open": 3.46, "adj_close": 3.25, "high": 3.46, "adj_volume": 407470.0, "low": 3.192, "date": "2016-01-28", "close": 3.25, "open": 3.46, "adj_high": 3.46, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 235289.0, "adj_low": 3.39, "adj_open": 3.59, "adj_close": 3.43, "high": 3.72, "adj_volume": 235289.0, "low": 3.39, "date": "2016-01-27", "close": 3.43, "open": 3.59, "adj_high": 3.72, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 160373.0, "adj_low": 3.46, "adj_open": 3.7, "adj_close": 3.58, "high": 3.7, "adj_volume": 160373.0, "low": 3.46, "date": "2016-01-26", "close": 3.58, "open": 3.7, "adj_high": 3.7, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 190096.0, "adj_low": 3.49, "adj_open": 3.58, "adj_close": 3.64, "high": 3.88, "adj_volume": 190096.0, "low": 3.49, "date": "2016-01-25", "close": 3.64, "open": 3.58, "adj_high": 3.88, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 305076.0, "adj_low": 3.56, "adj_open": 3.6, "adj_close": 3.59, "high": 3.7799, "adj_volume": 305076.0, "low": 3.56, "date": "2016-01-22", "close": 3.59, "open": 3.6, "adj_high": 3.7799, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 357809.0, "adj_low": 3.436, "adj_open": 3.54, "adj_close": 3.52, "high": 3.8, "adj_volume": 357809.0, "low": 3.436, "date": "2016-01-21", "close": 3.52, "open": 3.54, "adj_high": 3.8, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 360819.0, "adj_low": 3.22, "adj_open": 3.4, "adj_close": 3.51, "high": 3.58, "adj_volume": 360819.0, "low": 3.22, "date": "2016-01-20", "close": 3.51, "open": 3.4, "adj_high": 3.58, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 323319.0, "adj_low": 3.4, "adj_open": 3.8, "adj_close": 3.48, "high": 3.912, "adj_volume": 323319.0, "low": 3.4, "date": "2016-01-19", "close": 3.48, "open": 3.8, "adj_high": 3.912, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 390839.0, "adj_low": 3.61, "adj_open": 3.72, "adj_close": 3.7, "high": 3.79, "adj_volume": 390839.0, "low": 3.61, "date": "2016-01-15", "close": 3.7, "open": 3.72, "adj_high": 3.79, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 309729.0, "adj_low": 3.5764, "adj_open": 3.7, "adj_close": 3.81, "high": 3.92, "adj_volume": 309729.0, "low": 3.5764, "date": "2016-01-14", "close": 3.81, "open": 3.7, "adj_high": 3.92, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 484786.0, "adj_low": 3.6, "adj_open": 3.82, "adj_close": 3.72, "high": 3.99, "adj_volume": 484786.0, "low": 3.6, "date": "2016-01-13", "close": 3.72, "open": 3.82, "adj_high": 3.99, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 353954.0, "adj_low": 3.745, "adj_open": 3.87, "adj_close": 3.81, "high": 4.04, "adj_volume": 353954.0, "low": 3.745, "date": "2016-01-12", "close": 3.81, "open": 3.87, "adj_high": 4.04, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 449922.0, "adj_low": 3.69, "adj_open": 4.06, "adj_close": 3.84, "high": 4.06, "adj_volume": 449922.0, "low": 3.69, "date": "2016-01-11", "close": 3.84, "open": 4.06, "adj_high": 4.06, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 346215.0, "adj_low": 3.98, "adj_open": 4.15, "adj_close": 4.02, "high": 4.33, "adj_volume": 346215.0, "low": 3.98, "date": "2016-01-08", "close": 4.02, "open": 4.15, "adj_high": 4.33, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 469243.0, "adj_low": 4.0135, "adj_open": 4.15, "adj_close": 4.1, "high": 4.26, "adj_volume": 469243.0, "low": 4.0135, "date": "2016-01-07", "close": 4.1, "open": 4.15, "adj_high": 4.26, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 288806.0, "adj_low": 4.25, "adj_open": 4.46, "adj_close": 4.3, "high": 4.46, "adj_volume": 288806.0, "low": 4.25, "date": "2016-01-06", "close": 4.3, "open": 4.46, "adj_high": 4.46, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 207247.0, "adj_low": 4.45, "adj_open": 4.56, "adj_close": 4.51, "high": 4.71, "adj_volume": 207247.0, "low": 4.45, "date": "2016-01-05", "close": 4.51, "open": 4.56, "adj_high": 4.71, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 316811.0, "adj_low": 4.3619, "adj_open": 4.39, "adj_close": 4.52, "high": 4.62, "adj_volume": 316811.0, "low": 4.3619, "date": "2016-01-04", "close": 4.52, "open": 4.39, "adj_high": 4.62, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 481348.0, "adj_low": 4.412, "adj_open": 4.5, "adj_close": 4.45, "high": 4.53, "adj_volume": 481348.0, "low": 4.412, "date": "2015-12-31", "close": 4.45, "open": 4.5, "adj_high": 4.53, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 291897.0, "adj_low": 4.41, "adj_open": 4.52, "adj_close": 4.51, "high": 4.69, "adj_volume": 291897.0, "low": 4.41, "date": "2015-12-30", "close": 4.51, "open": 4.52, "adj_high": 4.69, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 205186.0, "adj_low": 4.48, "adj_open": 4.56, "adj_close": 4.57, "high": 4.63, "adj_volume": 205186.0, "low": 4.48, "date": "2015-12-29", "close": 4.57, "open": 4.56, "adj_high": 4.63, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 162747.0, "adj_low": 4.53, "adj_open": 4.69, "adj_close": 4.57, "high": 4.69, "adj_volume": 162747.0, "low": 4.53, "date": "2015-12-28", "close": 4.57, "open": 4.69, "adj_high": 4.69, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 114740.0, "adj_low": 4.61, "adj_open": 4.68, "adj_close": 4.74, "high": 4.77, "adj_volume": 114740.0, "low": 4.61, "date": "2015-12-24", "close": 4.74, "open": 4.68, "adj_high": 4.77, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 390157.0, "adj_low": 4.49, "adj_open": 4.49, "adj_close": 4.7, "high": 4.75, "adj_volume": 390157.0, "low": 4.49, "date": "2015-12-23", "close": 4.7, "open": 4.49, "adj_high": 4.75, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 238502.0, "adj_low": 4.475, "adj_open": 4.6, "adj_close": 4.53, "high": 4.65, "adj_volume": 238502.0, "low": 4.475, "date": "2015-12-22", "close": 4.53, "open": 4.6, "adj_high": 4.65, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 176006.0, "adj_low": 4.5226, "adj_open": 4.76, "adj_close": 4.62, "high": 4.79, "adj_volume": 176006.0, "low": 4.5226, "date": "2015-12-21", "close": 4.62, "open": 4.76, "adj_high": 4.79, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 301871.0, "adj_low": 4.6411, "adj_open": 4.68, "adj_close": 4.75, "high": 4.94, "adj_volume": 301871.0, "low": 4.6411, "date": "2015-12-18", "close": 4.75, "open": 4.68, "adj_high": 4.94, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 196938.0, "adj_low": 4.57, "adj_open": 4.68, "adj_close": 4.66, "high": 4.79, "adj_volume": 196938.0, "low": 4.57, "date": "2015-12-17", "close": 4.66, "open": 4.68, "adj_high": 4.79, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 546658.0, "adj_low": 4.55, "adj_open": 4.6, "adj_close": 4.71, "high": 4.72, "adj_volume": 546658.0, "low": 4.55, "date": "2015-12-16", "close": 4.71, "open": 4.6, "adj_high": 4.72, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 398387.0, "adj_low": 4.2501, "adj_open": 4.37, "adj_close": 4.56, "high": 4.59, "adj_volume": 398387.0, "low": 4.2501, "date": "2015-12-15", "close": 4.56, "open": 4.37, "adj_high": 4.59, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 336358.0, "adj_low": 4.25, "adj_open": 4.52, "adj_close": 4.34, "high": 4.666, "adj_volume": 336358.0, "low": 4.25, "date": "2015-12-14", "close": 4.34, "open": 4.52, "adj_high": 4.666, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 340974.0, "adj_low": 4.44, "adj_open": 4.62, "adj_close": 4.55, "high": 4.68, "adj_volume": 340974.0, "low": 4.44, "date": "2015-12-11", "close": 4.55, "open": 4.62, "adj_high": 4.68, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 491701.0, "adj_low": 4.552, "adj_open": 4.79, "adj_close": 4.67, "high": 4.89, "adj_volume": 491701.0, "low": 4.552, "date": "2015-12-10", "close": 4.67, "open": 4.79, "adj_high": 4.89, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 232789.0, "adj_low": 4.82, "adj_open": 4.9, "adj_close": 4.84, "high": 5.02, "adj_volume": 232789.0, "low": 4.82, "date": "2015-12-09", "close": 4.84, "open": 4.9, "adj_high": 5.02, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 199956.0, "adj_low": 4.86, "adj_open": 4.86, "adj_close": 4.88, "high": 5.11, "adj_volume": 199956.0, "low": 4.86, "date": "2015-12-08", "close": 4.88, "open": 4.86, "adj_high": 5.11, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 511156.0, "adj_low": 4.92, "adj_open": 5.23, "adj_close": 4.94, "high": 5.29, "adj_volume": 511156.0, "low": 4.92, "date": "2015-12-07", "close": 4.94, "open": 5.23, "adj_high": 5.29, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 243121.0, "adj_low": 5.25, "adj_open": 5.38, "adj_close": 5.29, "high": 5.44, "adj_volume": 243121.0, "low": 5.25, "date": "2015-12-04", "close": 5.29, "open": 5.38, "adj_high": 5.44, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 255805.0, "adj_low": 5.39, "adj_open": 5.59, "adj_close": 5.41, "high": 5.66, "adj_volume": 255805.0, "low": 5.39, "date": "2015-12-03", "close": 5.41, "open": 5.59, "adj_high": 5.66, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 252007.0, "adj_low": 5.51, "adj_open": 5.56, "adj_close": 5.58, "high": 5.7, "adj_volume": 252007.0, "low": 5.51, "date": "2015-12-02", "close": 5.58, "open": 5.56, "adj_high": 5.7, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 225819.0, "adj_low": 5.45, "adj_open": 5.64, "adj_close": 5.59, "high": 5.6734, "adj_volume": 225819.0, "low": 5.45, "date": "2015-12-01", "close": 5.59, "open": 5.64, "adj_high": 5.6734, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 388828.0, "adj_low": 5.45, "adj_open": 5.5, "adj_close": 5.58, "high": 5.79, "adj_volume": 388828.0, "low": 5.45, "date": "2015-11-30", "close": 5.58, "open": 5.5, "adj_high": 5.79, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 234372.0, "adj_low": 5.39, "adj_open": 5.47, "adj_close": 5.51, "high": 5.55, "adj_volume": 234372.0, "low": 5.39, "date": "2015-11-27", "close": 5.51, "open": 5.47, "adj_high": 5.55, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 399180.0, "adj_low": 5.42, "adj_open": 5.42, "adj_close": 5.47, "high": 5.52, "adj_volume": 399180.0, "low": 5.42, "date": "2015-11-25", "close": 5.47, "open": 5.42, "adj_high": 5.52, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 146009.0, "adj_low": 5.38, "adj_open": 5.38, "adj_close": 5.44, "high": 5.5, "adj_volume": 146009.0, "low": 5.38, "date": "2015-11-24", "close": 5.44, "open": 5.38, "adj_high": 5.5, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 230755.0, "adj_low": 5.38, "adj_open": 5.53, "adj_close": 5.42, "high": 5.54, "adj_volume": 230755.0, "low": 5.38, "date": "2015-11-23", "close": 5.42, "open": 5.53, "adj_high": 5.54, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 175250.0, "adj_low": 5.4, "adj_open": 5.66, "adj_close": 5.47, "high": 5.66, "adj_volume": 175250.0, "low": 5.4, "date": "2015-11-20", "close": 5.47, "open": 5.66, "adj_high": 5.66, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 264731.0, "adj_low": 5.55, "adj_open": 5.73, "adj_close": 5.65, "high": 5.88, "adj_volume": 264731.0, "low": 5.55, "date": "2015-11-19", "close": 5.65, "open": 5.73, "adj_high": 5.88, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 274700.0, "adj_low": 5.22, "adj_open": 5.31, "adj_close": 5.58, "high": 5.6, "adj_volume": 274700.0, "low": 5.22, "date": "2015-11-18", "close": 5.58, "open": 5.31, "adj_high": 5.6, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 322329.0, "adj_low": 5.25, "adj_open": 5.41, "adj_close": 5.27, "high": 5.67, "adj_volume": 322329.0, "low": 5.25, "date": "2015-11-17", "close": 5.27, "open": 5.41, "adj_high": 5.67, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 339231.0, "adj_low": 5.26, "adj_open": 5.52, "adj_close": 5.38, "high": 5.68, "adj_volume": 339231.0, "low": 5.26, "date": "2015-11-16", "close": 5.38, "open": 5.52, "adj_high": 5.68, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 262239.0, "adj_low": 5.3599, "adj_open": 5.5, "adj_close": 5.59, "high": 5.72, "adj_volume": 262239.0, "low": 5.3599, "date": "2015-11-13", "close": 5.59, "open": 5.5, "adj_high": 5.72, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 261526.0, "adj_low": 5.47, "adj_open": 5.72, "adj_close": 5.51, "high": 5.72, "adj_volume": 261526.0, "low": 5.47, "date": "2015-11-12", "close": 5.51, "open": 5.72, "adj_high": 5.72, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 275998.0, "adj_low": 5.65, "adj_open": 5.93, "adj_close": 5.67, "high": 5.93, "adj_volume": 275998.0, "low": 5.65, "date": "2015-11-11", "close": 5.67, "open": 5.93, "adj_high": 5.93, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 307981.0, "adj_low": 5.69, "adj_open": 6.06, "adj_close": 5.89, "high": 6.06, "adj_volume": 307981.0, "low": 5.69, "date": "2015-11-10", "close": 5.89, "open": 6.06, "adj_high": 6.06, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 405506.0, "adj_low": 5.83, "adj_open": 5.92, "adj_close": 6.08, "high": 6.12, "adj_volume": 405506.0, "low": 5.83, "date": "2015-11-09", "close": 6.08, "open": 5.92, "adj_high": 6.12, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 337936.0, "adj_low": 5.45, "adj_open": 5.67, "adj_close": 5.93, "high": 5.96, "adj_volume": 337936.0, "low": 5.45, "date": "2015-11-06", "close": 5.93, "open": 5.67, "adj_high": 5.96, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 700735.0, "adj_low": 5.75, "adj_open": 6.04, "adj_close": 5.77, "high": 6.12, "adj_volume": 700735.0, "low": 5.75, "date": "2015-11-05", "close": 5.77, "open": 6.04, "adj_high": 6.12, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 417030.0, "adj_low": 5.78, "adj_open": 5.86, "adj_close": 6.07, "high": 6.1199, "adj_volume": 417030.0, "low": 5.78, "date": "2015-11-04", "close": 6.07, "open": 5.86, "adj_high": 6.1199, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 420672.0, "adj_low": 5.67, "adj_open": 5.74, "adj_close": 5.87, "high": 6.12, "adj_volume": 420672.0, "low": 5.67, "date": "2015-11-03", "close": 5.87, "open": 5.74, "adj_high": 6.12, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 417291.0, "adj_low": 5.46, "adj_open": 5.5, "adj_close": 5.83, "high": 5.9, "adj_volume": 417291.0, "low": 5.46, "date": "2015-11-02", "close": 5.83, "open": 5.5, "adj_high": 5.9, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 362431.0, "adj_low": 5.41, "adj_open": 5.83, "adj_close": 5.5, "high": 5.9399, "adj_volume": 362431.0, "low": 5.41, "date": "2015-10-30", "close": 5.5, "open": 5.83, "adj_high": 5.9399, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 560827.0, "adj_low": 5.47, "adj_open": 5.98, "adj_close": 5.65, "high": 6.01, "adj_volume": 560827.0, "low": 5.47, "date": "2015-10-29", "close": 5.65, "open": 5.98, "adj_high": 6.01, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 324773.0, "adj_low": 5.87, "adj_open": 6.04, "adj_close": 5.99, "high": 6.2496, "adj_volume": 324773.0, "low": 5.87, "date": "2015-10-28", "close": 5.99, "open": 6.04, "adj_high": 6.2496, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 319910.0, "adj_low": 5.92, "adj_open": 5.99, "adj_close": 6.04, "high": 6.26, "adj_volume": 319910.0, "low": 5.92, "date": "2015-10-27", "close": 6.04, "open": 5.99, "adj_high": 6.26, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 182958.0, "adj_low": 5.68, "adj_open": 5.87, "adj_close": 6.01, "high": 6.09, "adj_volume": 182958.0, "low": 5.68, "date": "2015-10-26", "close": 6.01, "open": 5.87, "adj_high": 6.09, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 219854.0, "adj_low": 5.6084, "adj_open": 5.84, "adj_close": 5.87, "high": 5.97, "adj_volume": 219854.0, "low": 5.6084, "date": "2015-10-23", "close": 5.87, "open": 5.84, "adj_high": 5.97, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 438626.0, "adj_low": 5.45, "adj_open": 5.96, "adj_close": 5.78, "high": 6.03, "adj_volume": 438626.0, "low": 5.45, "date": "2015-10-22", "close": 5.78, "open": 5.96, "adj_high": 6.03, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 295515.0, "adj_low": 5.81, "adj_open": 6.28, "adj_close": 5.93, "high": 6.39, "adj_volume": 295515.0, "low": 5.81, "date": "2015-10-21", "close": 5.93, "open": 6.28, "adj_high": 6.39, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 267661.0, "adj_low": 6.02, "adj_open": 6.39, "adj_close": 6.25, "high": 6.4, "adj_volume": 267661.0, "low": 6.02, "date": "2015-10-20", "close": 6.25, "open": 6.39, "adj_high": 6.4, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 225096.0, "adj_low": 6.26, "adj_open": 6.38, "adj_close": 6.42, "high": 6.74, "adj_volume": 225096.0, "low": 6.26, "date": "2015-10-19", "close": 6.42, "open": 6.38, "adj_high": 6.74, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 444055.0, "adj_low": 6.01, "adj_open": 6.01, "adj_close": 6.46, "high": 6.55, "adj_volume": 444055.0, "low": 6.01, "date": "2015-10-16", "close": 6.46, "open": 6.01, "adj_high": 6.55, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 392463.0, "adj_low": 5.6, "adj_open": 5.6, "adj_close": 6.04, "high": 6.155, "adj_volume": 392463.0, "low": 5.6, "date": "2015-10-15", "close": 6.04, "open": 5.6, "adj_high": 6.155, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 260529.0, "adj_low": 5.5, "adj_open": 5.62, "adj_close": 5.61, "high": 5.89, "adj_volume": 260529.0, "low": 5.5, "date": "2015-10-14", "close": 5.61, "open": 5.62, "adj_high": 5.89, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 289974.0, "adj_low": 5.55, "adj_open": 5.9, "adj_close": 5.59, "high": 5.97, "adj_volume": 289974.0, "low": 5.55, "date": "2015-10-13", "close": 5.59, "open": 5.9, "adj_high": 5.97, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 240534.0, "adj_low": 5.85, "adj_open": 6.1, "adj_close": 5.93, "high": 6.1, "adj_volume": 240534.0, "low": 5.85, "date": "2015-10-12", "close": 5.93, "open": 6.1, "adj_high": 6.1, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 225114.0, "adj_low": 6.01, "adj_open": 6.25, "adj_close": 6.12, "high": 6.41, "adj_volume": 225114.0, "low": 6.01, "date": "2015-10-09", "close": 6.12, "open": 6.25, "adj_high": 6.41, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 342248.0, "adj_low": 5.91, "adj_open": 6.02, "adj_close": 6.26, "high": 6.3585, "adj_volume": 342248.0, "low": 5.91, "date": "2015-10-08", "close": 6.26, "open": 6.02, "adj_high": 6.3585, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 640019.0, "adj_low": 5.6, "adj_open": 6.11, "adj_close": 6.06, "high": 6.27, "adj_volume": 640019.0, "low": 5.6, "date": "2015-10-07", "close": 6.06, "open": 6.11, "adj_high": 6.27, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 338972.0, "adj_low": 5.85, "adj_open": 6.44, "adj_close": 6.12, "high": 6.47, "adj_volume": 338972.0, "low": 5.85, "date": "2015-10-06", "close": 6.12, "open": 6.44, "adj_high": 6.47, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 345944.0, "adj_low": 6.05, "adj_open": 6.26, "adj_close": 6.3, "high": 6.45, "adj_volume": 345944.0, "low": 6.05, "date": "2015-10-05", "close": 6.3, "open": 6.26, "adj_high": 6.45, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 387167.0, "adj_low": 6.14, "adj_open": 6.15, "adj_close": 6.2, "high": 6.54, "adj_volume": 387167.0, "low": 6.14, "date": "2015-10-02", "close": 6.2, "open": 6.15, "adj_high": 6.54, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 345457.0, "adj_low": 5.98, "adj_open": 6.07, "adj_close": 6.22, "high": 6.26, "adj_volume": 345457.0, "low": 5.98, "date": "2015-10-01", "close": 6.22, "open": 6.07, "adj_high": 6.26, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 519287.0, "adj_low": 5.75, "adj_open": 6.11, "adj_close": 6.09, "high": 6.17, "adj_volume": 519287.0, "low": 5.75, "date": "2015-09-30", "close": 6.09, "open": 6.11, "adj_high": 6.17, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 566150.0, "adj_low": 5.9, "adj_open": 6.63, "adj_close": 6.01, "high": 6.82, "adj_volume": 566150.0, "low": 5.9, "date": "2015-09-29", "close": 6.01, "open": 6.63, "adj_high": 6.82, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 975083.0, "adj_low": 6.35, "adj_open": 6.63, "adj_close": 6.58, "high": 6.74, "adj_volume": 975083.0, "low": 6.35, "date": "2015-09-28", "close": 6.58, "open": 6.63, "adj_high": 6.74, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 665878.0, "adj_low": 6.52, "adj_open": 7.33, "adj_close": 6.62, "high": 7.49, "adj_volume": 665878.0, "low": 6.52, "date": "2015-09-25", "close": 6.62, "open": 7.33, "adj_high": 7.49, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 693769.0, "adj_low": 6.67, "adj_open": 6.8, "adj_close": 7.3, "high": 7.34, "adj_volume": 693769.0, "low": 6.67, "date": "2015-09-24", "close": 7.3, "open": 6.8, "adj_high": 7.34, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 414219.0, "adj_low": 6.5, "adj_open": 6.68, "adj_close": 6.57, "high": 6.9099, "adj_volume": 414219.0, "low": 6.5, "date": "2015-09-23", "close": 6.57, "open": 6.68, "adj_high": 6.9099, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 298685.0, "adj_low": 6.62, "adj_open": 6.73, "adj_close": 6.81, "high": 7.04, "adj_volume": 298685.0, "low": 6.62, "date": "2015-09-22", "close": 6.81, "open": 6.73, "adj_high": 7.04, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 541459.0, "adj_low": 6.76, "adj_open": 7.32, "adj_close": 6.86, "high": 7.32, "adj_volume": 541459.0, "low": 6.76, "date": "2015-09-21", "close": 6.86, "open": 7.32, "adj_high": 7.32, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 308027.0, "adj_low": 7.26, "adj_open": 7.5, "adj_close": 7.31, "high": 7.65, "adj_volume": 308027.0, "low": 7.26, "date": "2015-09-18", "close": 7.31, "open": 7.5, "adj_high": 7.65, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 522424.0, "adj_low": 7.01, "adj_open": 7.04, "adj_close": 7.56, "high": 7.72, "adj_volume": 522424.0, "low": 7.01, "date": "2015-09-17", "close": 7.56, "open": 7.04, "adj_high": 7.72, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 388289.0, "adj_low": 6.86, "adj_open": 6.97, "adj_close": 7.11, "high": 7.13, "adj_volume": 388289.0, "low": 6.86, "date": "2015-09-16", "close": 7.11, "open": 6.97, "adj_high": 7.13, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 312454.0, "adj_low": 6.85, "adj_open": 7.0, "adj_close": 6.97, "high": 7.14, "adj_volume": 312454.0, "low": 6.85, "date": "2015-09-15", "close": 6.97, "open": 7.0, "adj_high": 7.14, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 428926.0, "adj_low": 6.8, "adj_open": 6.99, "adj_close": 7.0, "high": 7.06, "adj_volume": 428926.0, "low": 6.8, "date": "2015-09-14", "close": 7.0, "open": 6.99, "adj_high": 7.06, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 195387.0, "adj_low": 6.6175, "adj_open": 7.0, "adj_close": 6.89, "high": 7.05, "adj_volume": 195387.0, "low": 6.6175, "date": "2015-09-11", "close": 6.89, "open": 7.0, "adj_high": 7.05, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 228555.0, "adj_low": 6.76, "adj_open": 6.82, "adj_close": 6.97, "high": 6.99, "adj_volume": 228555.0, "low": 6.76, "date": "2015-09-10", "close": 6.97, "open": 6.82, "adj_high": 6.99, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 307191.0, "adj_low": 6.75, "adj_open": 7.06, "adj_close": 6.83, "high": 7.13, "adj_volume": 307191.0, "low": 6.75, "date": "2015-09-09", "close": 6.83, "open": 7.06, "adj_high": 7.13, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 325890.0, "adj_low": 6.98, "adj_open": 7.11, "adj_close": 7.05, "high": 7.22, "adj_volume": 325890.0, "low": 6.98, "date": "2015-09-08", "close": 7.05, "open": 7.11, "adj_high": 7.22, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 436903.0, "adj_low": 6.85, "adj_open": 6.85, "adj_close": 7.0, "high": 7.14, "adj_volume": 436903.0, "low": 6.85, "date": "2015-09-04", "close": 7.0, "open": 6.85, "adj_high": 7.14, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 749536.0, "adj_low": 6.83, "adj_open": 7.06, "adj_close": 6.93, "high": 7.155, "adj_volume": 749536.0, "low": 6.83, "date": "2015-09-03", "close": 6.93, "open": 7.06, "adj_high": 7.155, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 867099.0, "adj_low": 6.85, "adj_open": 6.92, "adj_close": 6.99, "high": 7.18, "adj_volume": 867099.0, "low": 6.85, "date": "2015-09-02", "close": 6.99, "open": 6.92, "adj_high": 7.18, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 511512.0, "adj_low": 6.67, "adj_open": 7.02, "adj_close": 6.76, "high": 7.08, "adj_volume": 511512.0, "low": 6.67, "date": "2015-09-01", "close": 6.76, "open": 7.02, "adj_high": 7.08, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 543360.0, "adj_low": 7.04, "adj_open": 7.34, "adj_close": 7.11, "high": 7.57, "adj_volume": 543360.0, "low": 7.04, "date": "2015-08-31", "close": 7.11, "open": 7.34, "adj_high": 7.57, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 514852.0, "adj_low": 7.15, "adj_open": 7.15, "adj_close": 7.36, "high": 7.48, "adj_volume": 514852.0, "low": 7.15, "date": "2015-08-28", "close": 7.36, "open": 7.15, "adj_high": 7.48, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 708423.0, "adj_low": 6.895, "adj_open": 7.1, "adj_close": 7.27, "high": 7.39, "adj_volume": 708423.0, "low": 6.895, "date": "2015-08-27", "close": 7.27, "open": 7.1, "adj_high": 7.39, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 746769.0, "adj_low": 6.42, "adj_open": 7.12, "adj_close": 7.0, "high": 7.39, "adj_volume": 746769.0, "low": 6.42, "date": "2015-08-26", "close": 7.0, "open": 7.12, "adj_high": 7.39, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 703700.0, "adj_low": 6.725, "adj_open": 7.06, "adj_close": 6.98, "high": 7.27, "adj_volume": 703700.0, "low": 6.725, "date": "2015-08-25", "close": 6.98, "open": 7.06, "adj_high": 7.27, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 507330.0, "adj_low": 6.23, "adj_open": 6.23, "adj_close": 6.93, "high": 7.18, "adj_volume": 507330.0, "low": 6.23, "date": "2015-08-24", "close": 6.93, "open": 6.23, "adj_high": 7.18, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 808410.0, "adj_low": 6.89, "adj_open": 7.25, "adj_close": 7.21, "high": 7.48, "adj_volume": 808410.0, "low": 6.89, "date": "2015-08-21", "close": 7.21, "open": 7.25, "adj_high": 7.48, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 613417.0, "adj_low": 7.23, "adj_open": 7.5, "adj_close": 7.28, "high": 7.78, "adj_volume": 613417.0, "low": 7.23, "date": "2015-08-20", "close": 7.28, "open": 7.5, "adj_high": 7.78, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 704966.0, "adj_low": 7.52, "adj_open": 8.23, "adj_close": 7.64, "high": 8.23, "adj_volume": 704966.0, "low": 7.52, "date": "2015-08-19", "close": 7.64, "open": 8.23, "adj_high": 8.23, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 575265.0, "adj_low": 7.99, "adj_open": 8.58, "adj_close": 8.23, "high": 8.77, "adj_volume": 575265.0, "low": 7.99, "date": "2015-08-18", "close": 8.23, "open": 8.58, "adj_high": 8.77, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 500963.0, "adj_low": 8.0, "adj_open": 8.49, "adj_close": 8.77, "high": 8.82, "adj_volume": 500963.0, "low": 8.0, "date": "2015-08-17", "close": 8.77, "open": 8.49, "adj_high": 8.82, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 548689.0, "adj_low": 8.27, "adj_open": 8.69, "adj_close": 8.49, "high": 8.88, "adj_volume": 548689.0, "low": 8.27, "date": "2015-08-14", "close": 8.49, "open": 8.69, "adj_high": 8.88, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 302656.0, "adj_low": 8.86, "adj_open": 8.9, "adj_close": 8.95, "high": 9.44, "adj_volume": 302656.0, "low": 8.86, "date": "2015-08-13", "close": 8.95, "open": 8.9, "adj_high": 9.44, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 506901.0, "adj_low": 8.64, "adj_open": 8.91, "adj_close": 9.1, "high": 9.53, "adj_volume": 506901.0, "low": 8.64, "date": "2015-08-12", "close": 9.1, "open": 8.91, "adj_high": 9.53, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 904865.0, "adj_low": 8.9601, "adj_open": 9.71, "adj_close": 9.11, "high": 10.0999, "adj_volume": 904865.0, "low": 8.9601, "date": "2015-08-11", "close": 9.11, "open": 9.71, "adj_high": 10.0999, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 359067.0, "adj_low": 9.9, "adj_open": 9.97, "adj_close": 10.02, "high": 10.41, "adj_volume": 359067.0, "low": 9.9, "date": "2015-08-10", "close": 10.02, "open": 9.97, "adj_high": 10.41, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 475492.0, "adj_low": 9.53, "adj_open": 9.93, "adj_close": 10.11, "high": 10.32, "adj_volume": 475492.0, "low": 9.53, "date": "2015-08-07", "close": 10.11, "open": 9.93, "adj_high": 10.32, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 449391.0, "adj_low": 9.67, "adj_open": 10.05, "adj_close": 9.95, "high": 10.33, "adj_volume": 449391.0, "low": 9.67, "date": "2015-08-06", "close": 9.95, "open": 10.05, "adj_high": 10.33, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 299487.0, "adj_low": 10.03, "adj_open": 10.2, "adj_close": 10.33, "high": 10.5, "adj_volume": 299487.0, "low": 10.03, "date": "2015-08-05", "close": 10.33, "open": 10.2, "adj_high": 10.5, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 403440.0, "adj_low": 10.15, "adj_open": 10.22, "adj_close": 10.48, "high": 11.5, "adj_volume": 403440.0, "low": 10.15, "date": "2015-08-04", "close": 10.48, "open": 10.22, "adj_high": 11.5, "split_ratio": 1.0}, {"ex_dividend": 0.0, "volume": 193043.0, "adj_low": 10.22, "adj_open": 10.78, "adj_close": 10.5, "high": 11.2, "adj_volume": 193043.0, "low": 10.22, "date": "2015-08-03", "close": 10.5, "open": 10.78, "adj_high": 11.2, "split_ratio": 1.0}], "result_count": 382}, "news": {"current_page": 1, "total_pages": 1, "page_size": 250, "api_call_credits": 1, "data": [{"url": "http://finance.yahoo.com/news/celgene-issues-preliminary-2016-results-135501244.html", "publication_date": "2017-01-10 13:55:01 +0000", "summary": "Celgene Issues Preliminary 2016 Results, Lifts 2017 View", "title": "Celgene Issues Preliminary 2016 Results, Lifts 2017 View"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ll_4LNj1PLI/ionis-novartis-ink-deal-to-focus-on-cardiovascular-treatments-cm730965", "publication_date": "2017-01-09 15:53:07 +0000", "summary": "Ionis Pharmaceuticals Inc IONS along with its subsidiary Akcea Therapeutics announced that the company has entered into an exclusive worldwide collaboration agreement with Novartis AG NVS for the development and commercialization of two novel treatments AKCEA APO a L and AKCEA APOCIII", "title": "Ionis, Novartis Ink Deal to Focus on Cardiovascular Treatments"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OcJ2DNAj_Is/the-medicines-co-ldl-lowering-drug-positive-in-phase-ii-cm731030", "publication_date": "2017-01-09 14:52:51 +0000", "summary": "The Medicines Company MDCO announced positive top line results from a Day 180 interim analysis of the ongoing ORION 1 phase II study on its pipeline candidate Inclisiran formerly PCSK9si for the treatment of hypercholesterolemia The Medicines Company is developing Inclisiran under", "title": "The Medicines Co LDL-Lowering Drug Positive in Phase II"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l2RcZdQ0GRw/alexion-blood-disorder-drug-gets-orphan-designation-in-us-cm731027", "publication_date": "2017-01-09 14:52:42 +0000", "summary": "Alexion Pharmaceuticals Inc ALXN announced that the FDA has granted orphan drug designation ODD to ALXN1210 a longer acting anti C5 antibody that inhibits terminal complement for the treatment of patients with paroxysmal nocturnal hemoglobinuria PNH a debilitating ultra", "title": "Alexion Blood Disorder Drug Gets Orphan Designation in U.S."}, {"url": "http://finance.yahoo.com/news/ionis-novartis-ink-deal-focus-140102417.html", "publication_date": "2017-01-09 14:01:02 +0000", "summary": "Ionis, Novartis Ink Deal to Focus on Cardiovascular Treatments", "title": "Ionis, Novartis Ink Deal to Focus on Cardiovascular Treatments"}, {"url": "http://finance.yahoo.com/news/alexion-blood-disorder-drug-gets-131501450.html", "publication_date": "2017-01-09 13:15:01 +0000", "summary": "Alexion Blood Disorder Drug Gets Orphan Designation in U.S.", "title": "Alexion Blood Disorder Drug Gets Orphan Designation in U.S."}, {"url": "http://finance.yahoo.com/news/medicines-co-ldl-lowering-drug-131201805.html", "publication_date": "2017-01-09 13:12:01 +0000", "summary": "The Medicines Co LDL-Lowering Drug Positive in Phase II", "title": "The Medicines Co LDL-Lowering Drug Positive in Phase II"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VYMHsePO6D0/ultragenyxs-rare-krn23-accepted-for-review-in-the-eu-cm730343", "publication_date": "2017-01-06 14:40:28 +0000", "summary": "Ultragenyx Pharmaceutical Inc RARE announced that the European Medicines Agency EMA has accepted to review the company s Marketing Authorization Application MAA for KRN23 for the treatment of X linked hypophosphatemia XLH KRN23 an antibody targeting fibroblast growth factor", "title": "Ultragenyx's (RARE) KRN23 Accepted for Review in the EU"}, {"url": "http://finance.yahoo.com/news/ultragenyxs-rare-krn23-accepted-review-131801746.html", "publication_date": "2017-01-06 13:18:01 +0000", "summary": "Ultragenyx's (RARE) KRN23 Accepted for Review in the EU", "title": "Ultragenyx's (RARE) KRN23 Accepted for Review in the EU"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pw4sLEZ9kOU/ionis-ions-stock-up-on-positive-type-ii-diabetes-drug-data-cm729791", "publication_date": "2017-01-05 14:41:14 +0000", "summary": "Shares of Ionis Pharmaceuticals Inc IONS were up 4 2 after the company announced encouraging data from a phase II study on IONIS GCGR for the treatment type II diabetes Ionis share price movement in 2016 shows that the company has outperformed the Zacks classified Medical", "title": "Ionis (IONS) Stock Up on Positive Type II Diabetes Drug Data"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vyh7uxA3U_M/bayers-snda-for-stivarga-granted-priority-review-in-the-us-cm729786", "publication_date": "2017-01-05 14:40:58 +0000", "summary": "Bayer AG BAYRY announced that the FDA has granted priority review designation to the company s supplemental New Drug Application sNDA for its cancer drug Stivarga for the second line treatment of patients with unresectable hepatocellular carcinoma uHCC Bayer s share price movement", "title": "Bayer's sNDA for Stivarga Granted Priority Review in the U.S."}, {"url": "http://finance.yahoo.com/news/bayers-snda-stivarga-granted-priority-131501224.html", "publication_date": "2017-01-05 13:15:01 +0000", "summary": "Bayer's sNDA for Stivarga Granted Priority Review in the U.S.", "title": "Bayer's sNDA for Stivarga Granted Priority Review in the U.S."}, {"url": "http://finance.yahoo.com/news/ionis-ions-stock-positive-type-131101529.html", "publication_date": "2017-01-05 13:11:01 +0000", "summary": "Ionis (IONS) Stock Up on Positive Type II Diabetes Drug Data", "title": "Ionis (IONS) Stock Up on Positive Type II Diabetes Drug Data"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EYiPXOO8QyM/innocoll-innl-down-on-fdas-refusal-to-file-xaracoll-nda-cm727816", "publication_date": "2016-12-30 16:01:41 +0000", "summary": "Innocoll Holdings plc INNL announced that it has received a Refusal to File letter from the FDA in connection with the New Drug Application NDA for its pipeline candidate Xaracoll bupivacaine HCl collagen matrix implants for the treatment of postsurgical pain Following", "title": "Innocoll (INNL) Down on FDA's Refusal to File Xaracoll NDA"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ejZgrOqP2qA/fortress-biotech-fbio-in-focus-stock-moves-209-higher-cm727907", "publication_date": "2016-12-30 15:02:02 +0000", "summary": "Fortress Biotech Inc FBIO was a big mover last session as its shares rose almost 21 on the day The move came after the company reported breakthrough with CAR T cancer approach This led to far more shares changing hands than in a normal session This breaks the recent trend of the", "title": "Fortress Biotech (FBIO) in Focus: Stock Moves 20.9% Higher"}, {"url": "http://finance.yahoo.com/news/innocoll-innl-down-fdas-refusal-141202356.html", "publication_date": "2016-12-30 14:12:02 +0000", "summary": "Innocoll (INNL) Down on FDA's Refusal to File Xaracoll NDA", "title": "Innocoll (INNL) Down on FDA's Refusal to File Xaracoll NDA"}, {"url": "http://finance.yahoo.com/news/fortress-biotech-fbio-focus-stock-132501694.html", "publication_date": "2016-12-30 13:25:01 +0000", "summary": "Fortress Biotech (FBIO) in Focus: Stock Moves 20.9% Higher", "title": "Fortress Biotech (FBIO) in Focus: Stock Moves 20.9% Higher"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TgaJULbeC5k/galena-biopharma-reveals-regulatory-pathway-for-gale-401-cm727428", "publication_date": "2016-12-29 16:58:14 +0000", "summary": "Galena Biopharma Inc s GALE shares surged 21 4 after the company confirmed the regulatory pathway to advance GALE 401 anagrelide CR into a pivotal phase III study Galena s year to date share price movement shows that the company has underperformed the Zacks", "title": "Galena Biopharma Reveals Regulatory Pathway for GALE-401"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PksJpg6_rCg/intercept-pharmaceuticals-icpt-jumps-stock-rises-93-cm727373", "publication_date": "2016-12-29 16:02:57 +0000", "summary": "Intercept Pharmaceuticals Inc ICPT was a big mover last session as the company saw its shares rise over 9 on the day The move came on solid volume with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above", "title": "Intercept Pharmaceuticals (ICPT) Jumps: Stock Rises 9.3%"}, {"url": "http://finance.yahoo.com/news/galena-biopharma-reveals-regulatory-pathway-150803241.html", "publication_date": "2016-12-29 15:08:03 +0000", "summary": "Galena Biopharma Reveals Regulatory Pathway for GALE-401", "title": "Galena Biopharma Reveals Regulatory Pathway for GALE-401"}, {"url": "http://finance.yahoo.com/news/intercept-pharmaceuticals-icpt-jumps-stock-134501048.html", "publication_date": "2016-12-29 13:45:01 +0000", "summary": "Intercept Pharmaceuticals (ICPT) Jumps: Stock Rises 9.3%", "title": "Intercept Pharmaceuticals (ICPT) Jumps: Stock Rises 9.3%"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ckooJQb3qHM/anthera-anth-stock-falls-on-poor-phase-iii-sollpura-data-cm726921", "publication_date": "2016-12-28 16:57:48 +0000", "summary": "Anthera Pharmaceuticals Inc ANTH announced disappointing top line data from a phase III study SOLUTION on one of its pipeline candidates Sollpura liprotamase in cystic fibrosis patients with exocrine pancreatic insufficiency EPI Shares of the company plunged 58 2 on Dec 27", "title": "Anthera (ANTH) Stock Falls on Poor Phase III Sollpura Data"}, {"url": "http://finance.yahoo.com/news/anthera-anth-stock-falls-poor-152003359.html", "publication_date": "2016-12-28 15:20:03 +0000", "summary": "Anthera (ANTH) Stock Falls on Poor Phase III Sollpura Data", "title": "Anthera (ANTH) Stock Falls on Poor Phase III Sollpura Data"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CvbqDne92P8/newlink-genetics-nlnk-jumps-stock-adds-10-in-session-cm726433", "publication_date": "2016-12-27 15:00:53 +0000", "summary": "NewLink Genetics Corporation NLNK was a big mover last session as the company saw its shares rise almost 10 on the day The move came on solid volume with far more shares changing hands than in a normal session This reverses the recent trend of the company as the stock is now down 15 in", "title": "NewLink Genetics (NLNK) Jumps: Stock Adds 10% in Session"}, {"url": "http://finance.yahoo.com/news/newlink-genetics-nlnk-jumps-stock-133001124.html", "publication_date": "2016-12-27 13:30:01 +0000", "summary": "NewLink Genetics (NLNK) Jumps: Stock Adds 10% in Session", "title": "NewLink Genetics (NLNK) Jumps: Stock Adds 10% in Session"}, {"url": "http://finance.yahoo.com/news/spring-bank-sbph-inks-3rd-190000079.html", "publication_date": "2016-12-23 19:00:00 +0000", "summary": "Spring Bank (SBPH) Inks 3rd Collaboration Agreement", "title": "Spring Bank (SBPH) Inks 3rd Collaboration Agreement"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OVD_91zg7co/alexion-soliris-fails-in-phase-iiiii-delayed-graft-function-study-cm724988", "publication_date": "2016-12-22 14:59:44 +0000", "summary": "Alexion Pharmaceuticals Inc ALXN announced that Soliris has failed to meet the primary endpoint in a randomized parallel group double blind placebo controlled multi center phase II III study PROTECT We expect investors to react negatively to the news Alexion s year to date share", "title": "Alexion Soliris Fails in Phase II/III Delayed Graft Function Study"}, {"url": "http://finance.yahoo.com/news/alexion-soliris-fails-phase-ii-130301683.html", "publication_date": "2016-12-22 13:03:01 +0000", "summary": "Alexion Soliris Fails in Phase II/III Delayed Graft Function Study", "title": "Alexion Soliris Fails in Phase II/III Delayed Graft Function Study"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HHTvF_w7Qps/celgene-celg-otezla-approved-in-japan-for-two-indications-cm724517", "publication_date": "2016-12-21 16:01:51 +0000", "summary": "Celgene Corporation CELG received encouraging news with the Japanese Ministry of Health Labor and Welfare granting full marketing authorization to its oral phosphodiesterase 4 PDE4 Otezla Otezla has been approved for the treatment of adults with plaque psoriasis with an inadequate", "title": "Celgene (CELG) Otezla Approved in Japan for Two Indications"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xv-I1EoMDE0/bristol-myers-psioxus-ink-deal-for-oncolytic-virus-therapy-cm724506", "publication_date": "2016-12-21 16:01:24 +0000", "summary": "Bristol Myers Squibb Company BMY announced that it has entered into an agreement with PsiOxus Therapeutics Ltd under which it will gain exclusive worldwide rights to the latter s armed oncolytic virus candidate NG 348 currently in pre clinical development for the treatment of solid", "title": "Bristol-Myers, PsiOxus Ink Deal for Oncolytic Virus Therapy"}, {"url": "http://finance.yahoo.com/news/bristol-myers-psioxus-ink-deal-134901467.html", "publication_date": "2016-12-21 13:49:01 +0000", "summary": "Bristol-Myers, PsiOxus Ink Deal for Oncolytic Virus Therapy", "title": "Bristol-Myers, PsiOxus Ink Deal for Oncolytic Virus Therapy"}, {"url": "http://finance.yahoo.com/news/celgene-celg-otezla-approved-japan-134201359.html", "publication_date": "2016-12-21 13:42:01 +0000", "summary": "Celgene (CELG) Otezla Approved in Japan for Two Indications", "title": "Celgene (CELG) Otezla Approved in Japan for Two Indications"}, {"url": "http://www.publicnow.com/view/EC34B0A7736BC52EA119E238E274C4E55C38B3D5", "publication_date": "2016-12-19 12:11:05 +0000", "summary": "[at noodls] - HOPKINTON, Mass., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...", "title": "Spring Bank and Arbutus Biopharma Announce Preclinical Collaboration in Study of Chronic Hepatitis B"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mIihIFGITVs/syndax-pharmaceuticals-sndx-looks-good-stock-up-143-cm721915", "publication_date": "2016-12-15 14:59:30 +0000", "summary": "Syndax Pharmaceuticals Inc SNDX was a big mover last session as the company saw its shares rise over 14 on the day The upside was driven after the company announced entering into a Cooperative Research and Development Agreement CRADA with the National Cancer Institute NCI The news", "title": "Syndax Pharmaceuticals (SNDX) Looks Good: Stock Up 14.3%"}, {"url": "http://finance.yahoo.com/news/syndax-pharmaceuticals-sndx-looks-good-133001571.html", "publication_date": "2016-12-15 13:30:01 +0000", "summary": "Syndax Pharmaceuticals (SNDX) Looks Good: Stock Up 14.3%", "title": "Syndax Pharmaceuticals (SNDX) Looks Good: Stock Up 14.3%"}, {"url": "http://www.forbes.com/sites/nathanvardi/2016/12/14/modernas-mysterious-medicines/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahoofeed&partner=yahoomag", "publication_date": "2016-12-14 11:56:00 +0000", "summary": "Moderna's Mysterious Medicines", "title": "Moderna's Mysterious Medicines"}, {"url": "http://finance.yahoo.com/q/ud?s=ABUS", "publication_date": "2016-12-13 11:34:43 +0000", "summary": "Arbutus Biopharma downgraded by Chardan Capital Markets", "title": "Arbutus Biopharma downgraded by Chardan Capital Markets"}, {"url": "http://www.insidermonkey.com/blog/is-arbutus-biopharma-corp-abus-worthy-of-your-portfolio-504024/", "publication_date": "2016-12-12 23:21:09 +0000", "summary": "Is Arbutus Biopharma Corp (ABUS) Worthy of Your Portfolio?", "title": "Is Arbutus Biopharma Corp (ABUS) Worthy of Your Portfolio?"}, {"url": "http://biz.yahoo.com/e/161212/abus8-k.html", "publication_date": "2016-12-12 21:02:48 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events"}, {"url": "http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#abus", "publication_date": "2016-12-12 21:01:00 +0000", "summary": "4:01 pm Arbutus Biopharma reports new results from the ongoing Phase II study of ARB-1467 in chronically infected HBV patients on stable nucleos(t)ide therapy", "title": "4:01 pm Arbutus Biopharma reports new results from the ongoing Phase II study of ARB-1467 in chronically infected HBV patients on stable nucleos(t)ide therapy"}, {"url": "http://finance.yahoo.com/news/arbutus-provides-additional-data-arb-210000970.html", "publication_date": "2016-12-12 21:00:00 +0000", "summary": "[GlobeNewswire] - Complete Cohort 1 and 2 ARB-1467 Multi-Dose Data Demonstrate Dose-Responsive HBsAg Reductions Greater Than 1.0 log 10 Reduction in Serum HBsAg Observed in 3/ 5 Patients After Receiving Three Monthly Doses ...", "title": "Arbutus Provides Additional Data from the ARB-1467 Phase II Clinical Trial in HBV Patients"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5UkKy-ynabY/should-you-get-rid-of-emergent-biosolutions-ebs-now-cm719336", "publication_date": "2016-12-09 17:00:34 +0000", "summary": "Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your portfolio", "title": "Should You Get Rid of Emergent BioSolutions (EBS) Now?"}, {"url": "http://finance.yahoo.com/news/rid-emergent-biosolutions-ebs-now-143702501.html", "publication_date": "2016-12-09 14:37:02 +0000", "summary": "Should You Get Rid of Emergent BioSolutions (EBS) Now?", "title": "Should You Get Rid of Emergent BioSolutions (EBS) Now?"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D4kTUm83eSQ/roche-presents-positive-follicular-lymphoma-data-on-gazvya-cm717738", "publication_date": "2016-12-06 23:57:09 +0000", "summary": "Roche Holding AG RHHBY announced encouraging data from the pivotal phase III study GALLIUM which compared Gazyva plus chemotherapy followed by Gazyva alone head to head against MabThera plus chemotherapy followed by MabThera alone in patients with previously untreated follicular lymphoma", "title": "Roche Presents Positive Follicular Lymphoma Data on Gazvya"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hZ-Axg8XSvY/pfizer-leukemia-drug-meets-primary-endpoint-in-phase-iii-cm717610", "publication_date": "2016-12-06 21:27:06 +0000", "summary": "Pfizer Inc PFE and partner Avillion LLP announced that a phase III study BFORE evaluating its marketed drug Bosulif in the first line setting met the primary endpoint Results from the BFORE study demonstrated superiority of Bosulif bosutinib over Glivec for the first line treatment", "title": "Pfizer Leukemia Drug Meets Primary Endpoint in Phase III"}, {"url": "http://finance.yahoo.com/news/roche-presents-positive-follicular-lymphoma-212609553.html", "publication_date": "2016-12-06 21:26:09 +0000", "summary": "Roche Presents Positive Follicular Lymphoma Data on Gazvya", "title": "Roche Presents Positive Follicular Lymphoma Data on Gazvya"}, {"url": "http://finance.yahoo.com/news/pfizer-leukemia-drug-meets-primary-151203064.html", "publication_date": "2016-12-06 15:12:03 +0000", "summary": "Pfizer Leukemia Drug Meets Primary Endpoint in Phase III", "title": "Pfizer Leukemia Drug Meets Primary Endpoint in Phase III"}, {"url": "http://finance.yahoo.com/news/strong-buy-stocks-december-5th-133101689.html", "publication_date": "2016-12-05 13:31:01 +0000", "summary": "New Strong Buy Stocks for December 5th", "title": "New Strong Buy Stocks for December 5th"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DnPLJ9iaOEM/health-care-sector-update-for-11302016-abuscsbrarwr-cm716036", "publication_date": "2016-11-30 21:55:42 +0000", "summary": "Top Health Care StocksTop Health Care Stocks JNJ 0 87 JNJ 0 87 PFE 0 91 PFE 0 91 MRK 1 46 MRK 1 46 ABT 1 45 ABT 1 45 AMGN 1 12 AMGN 1 12 Health care stocks ended mostly lower with the NYSE Health Care Index slipping almost 0 4 while shares of health care companies in the S amp", "title": "Health Care Sector Update for 11/30/2016: ABUS,CSBR,ARWR"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Up-Vni_j_Cc/foamix-completes-enrolment-in-phase-iii-acne-drug-studies-cm715764", "publication_date": "2016-11-30 16:59:09 +0000", "summary": "Foamix Pharmaceuticals Ltd FOMX announced that it has completed patient enrollment in two phase III studies that will evaluate the efficacy and safety of one of its pipeline candidates FMX101 topical 4 minocycline foam for the treatment of moderate to severe acne In the study", "title": "Foamix Completes Enrolment in Phase III Acne Drug Studies"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4tO9CRu55KI/aimmune-closes-enrolment-in-phase-iii-peanut-allergy-study-cm715742", "publication_date": "2016-11-30 16:58:07 +0000", "summary": "Aimmune Therapeutics Inc AIMT announced that it has completed global enrollment in the phase III PALISADE study on AR101 for the desensitization of patients with peanut allergy Aimmune anticipates top line data from the study in the fourth quarter of 2017 Positive data would allow", "title": "Aimmune Closes Enrolment in Phase III Peanut Allergy Study"}, {"url": "http://finance.yahoo.com/news/aimmune-closes-enrolment-phase-iii-150503656.html", "publication_date": "2016-11-30 15:05:03 +0000", "summary": "Aimmune Closes Enrolment in Phase III Peanut Allergy Study", "title": "Aimmune Closes Enrolment in Phase III Peanut Allergy Study"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mMEU4KKNzoY/valeant-vrx-ups-sales-force-to-support-xifaxanrelistor-cm715682", "publication_date": "2016-11-30 14:56:39 +0000", "summary": "Valeant Pharmaceuticals International Inc VRX announced that it is expanding its sales force to reach primary care physicians The new sales force team is going to promote the company s two products Xifaxan for irritable bowel syndrome with diarrhea IBS D and Relistor for opioid", "title": "Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor"}, {"url": "http://finance.yahoo.com/news/foamix-completes-enrolment-phase-iii-145002604.html", "publication_date": "2016-11-30 14:50:02 +0000", "summary": "Foamix Completes Enrolment in Phase III Acne Drug Studies", "title": "Foamix Completes Enrolment in Phase III Acne Drug Studies"}, {"url": "http://finance.yahoo.com/news/valeant-vrx-ups-sales-force-133201087.html", "publication_date": "2016-11-30 13:32:01 +0000", "summary": "Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor", "title": "Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wrLgCpW49js/after-hours-most-active-for-nov-29-2016-yhoo-ge-chk-mdrx-csco-xlnx-swnc-abus-tmusp-abbv-tsm-fcam-cm715383", "publication_date": "2016-11-29 22:02:59 +0000", "summary": "The NASDAQ 100 After Hours Indicator is up 68 to 4 873 89 The total After hours volume is currently 42 152 437 shares traded The following are the most active stocks for the after hours session Yahoo Inc YHOO is unchanged at 41 60 with 5 253 824 shares", "title": "After Hours Most Active for Nov 29, 2016 :  YHOO, GE, CHK, MDRX, CSCO, XLNX, SWNC, ABUS, TMUSP, ABBV, TSM, FCAM"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TvLKTO6CSuE/epizyme-tazemetostat-gets-fast-track-designation-in-us-cm715069", "publication_date": "2016-11-29 15:58:23 +0000", "summary": "Epizyme Inc s EPZM lead pipeline candidate tazemetostat an EZH2 inhibitor has received Fast Track designation in the U S for the treatment of patients with relapsed or refractory diffuse large B cell lymphoma DCBL whose tumors carry an EZH2 activating mutation This designation", "title": "Epizyme Tazemetostat Gets Fast Track Designation in U.S."}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WWAr7tugltA/jazz-completes-patient-enrollment-in-jzp-110-narcolepsy-trial-cm714950", "publication_date": "2016-11-29 14:58:48 +0000", "summary": "Jazz Pharmaceuticals Public Limited Company JAZZ announced that its phase III study evaluating JZP 110 has completed patient enrollment The study is evaluating JZP 110 for the treatment of excessive sleepiness ES associated with narcolepsy The phase III narcolepsy study is a double", "title": "Jazz Completes Patient Enrollment in JZP-110 Narcolepsy Trial"}, {"url": "http://finance.yahoo.com/news/epizyme-tazemetostat-gets-fast-track-135601592.html", "publication_date": "2016-11-29 13:56:01 +0000", "summary": "Epizyme Tazemetostat Gets Fast Track Designation in U.S.", "title": "Epizyme Tazemetostat Gets Fast Track Designation in U.S."}, {"url": "http://finance.yahoo.com/news/jazz-completes-patient-enrollment-jzp-125112262.html", "publication_date": "2016-11-29 12:51:12 +0000", "summary": "Jazz Completes Patient Enrollment in JZP-110 Narcolepsy Trial", "title": "Jazz Completes Patient Enrollment in JZP-110 Narcolepsy Trial"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ve1_13kAROg/new-strong-buy-stocks-for-november-28th-cm714687", "publication_date": "2016-11-28 19:57:32 +0000", "summary": "Here are 5 stocks added to the Zacks Rank 1 Strong Buy List today Arbutus Biopharma Corporation ABUS This biopharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings surging 19 3 over the last 30 days ARBUTUS BIOPH Price and", "title": "New Strong Buy Stocks for November 28th"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dzfSWetryoU/intellipharmaceutics-submits-nda-for-pain-treatment-rexista-cm714422", "publication_date": "2016-11-28 15:32:26 +0000", "summary": "Intellipharmaceutics International Inc IPCI announced that it has filed a new drug application NDA with the FDA for Rexista abuse deterrent oxycodone hydrochloride extended release tablets in the 10 mg 15 mg 20 mg 30 mg 40 mg 60 mg and 80 mg strengths The company is looking to", "title": "Intellipharmaceutics Submits NDA for Pain Treatment Rexista"}, {"url": "http://finance.yahoo.com/news/intellipharmaceutics-submits-nda-pain-treatment-134201302.html", "publication_date": "2016-11-28 13:42:01 +0000", "summary": "Intellipharmaceutics Submits NDA for Pain Treatment Rexista", "title": "Intellipharmaceutics Submits NDA for Pain Treatment Rexista"}, {"url": "http://finance.yahoo.com/news/strong-buy-stocks-november-28th-133501134.html", "publication_date": "2016-11-28 13:35:01 +0000", "summary": "New Strong Buy Stocks for November 28th", "title": "New Strong Buy Stocks for November 28th"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jn8wQnAAzhg/opko-health-opk-launches-kidney-drug-rayaldee-in-us-cm713975", "publication_date": "2016-11-25 16:06:54 +0000", "summary": "OPKO Health Inc OPK announced the launch of its kidney drug Rayaldee calcifediol The company said it will begin shipping of the drug to distributors in the United States on Nov 29 2016 Rayaldee extended release capsules were approved by the FDA in June this year for treating", "title": "OPKO Health (OPK) Launches Kidney Drug Rayaldee in U.S."}, {"url": "http://finance.yahoo.com/news/opko-health-opk-launches-kidney-133201226.html", "publication_date": "2016-11-25 13:32:01 +0000", "summary": "OPKO Health (OPK) Launches Kidney Drug Rayaldee in U.S.", "title": "OPKO Health (OPK) Launches Kidney Drug Rayaldee in U.S."}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LJ8tkhlYTjg/merck-mrk-announces-22-increase-in-quarterly-dividend-cm713647", "publication_date": "2016-11-24 15:06:23 +0000", "summary": "Merck amp Co Inc MRK recently announced a 2 2 hike in its quarterly dividend The company will now pay shareholders a quarterly dividend of 47 cents compared with the previous payout of 46 cents Based on the closing price of 61 64 on Nov 23 the increased payout translates to a yield", "title": "Merck (MRK) Announces 2.2% Increase in Quarterly Dividend"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7KGtGlzc_X0/junos-rocket-study-on-clinical-hold-again-shares-down-cm713620", "publication_date": "2016-11-24 14:05:45 +0000", "summary": "Juno Therapeutics Inc JUNO announced that it has voluntarily placed a phase II trial of its lead pipeline candidate JCAR015 on hold after two patients suffered cerebral edema earlier in the week One of the patients died and the other has very low chances of recovery The ROCKET trial", "title": "Juno's ROCKET Study on Clinical Hold Again, Shares Down"}, {"url": "http://finance.yahoo.com/news/merck-mrk-announces-2-2-133001159.html", "publication_date": "2016-11-24 13:30:01 +0000", "summary": "Merck (MRK) Announces 2.2% Increase in Quarterly Dividend", "title": "Merck (MRK) Announces 2.2% Increase in Quarterly Dividend"}, {"url": "http://finance.yahoo.com/news/junos-rocket-study-clinical-hold-123112135.html", "publication_date": "2016-11-24 12:31:12 +0000", "summary": "Juno's ROCKET Study on Clinical Hold Again, Shares Down", "title": "Juno's ROCKET Study on Clinical Hold Again, Shares Down"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mlF9rCL_WFo/novo-nordisks-diabetes-combination-drug-gets-fdas-nod-cm713240", "publication_date": "2016-11-23 16:05:45 +0000", "summary": "Novo Nordisk A S NVO received favorable news with the FDA approving its new drug application for Xultophy 100 3 6 Xultophy 100 3 6 is approved as an adjunct to diet and exercise to improve glycemic control in adults with type II diabetes mellitus who have inadequately controlled their disease", "title": "Novo Nordisk's Diabetes Combination Drug Gets FDA's Nod"}, {"url": "http://finance.yahoo.com/news/novo-nordisks-diabetes-combination-drug-141302828.html", "publication_date": "2016-11-23 14:13:02 +0000", "summary": "Novo Nordisk's Diabetes Combination Drug Gets FDA's Nod", "title": "Novo Nordisk's Diabetes Combination Drug Gets FDA's Nod"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dYq39BZg1Zo/novartis-nvs-reports-favorable-data-on-enbrel-biosimilar-cm711969", "publication_date": "2016-11-21 16:53:26 +0000", "summary": "Novartis AG s NVS generic arm Sandoz announced the publication of results from EGALITY study in the British Journal of Dermatology The study showed that its biosimilar version of Amgen Inc s AMGN blockbuster drug Enbrel Erelzi is equivalent to the originator product in more than 500", "title": "Novartis (NVS) Reports Favorable Data on Enbrel Biosimilar"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pnlu8hHVlXE/agios-presents-data-from-dose-expansion-study-of-ag-120-cm711888", "publication_date": "2016-11-21 15:52:25 +0000", "summary": "Agios Pharmaceuticals Inc AGIO announced first data from a phase I study on AG 120 an oral first in class IDH1 mutant inhibitor which is being evaluated as a single agent for the treatment of isocitrate dehydrogenase 1 IDH1 mutant positive glioma and chondrosarcoma The study is part", "title": "Agios Presents Data from Dose Expansion Study of AG-120"}, {"url": "http://finance.yahoo.com/news/novartis-nvs-reports-favorable-data-145902448.html", "publication_date": "2016-11-21 14:59:02 +0000", "summary": "Novartis (NVS) Reports Favorable Data on Enbrel Biosimilar", "title": "Novartis (NVS) Reports Favorable Data on Enbrel Biosimilar"}, {"url": "http://finance.yahoo.com/news/agios-presents-data-dose-expansion-140002372.html", "publication_date": "2016-11-21 14:00:02 +0000", "summary": "Agios Presents Data from Dose Expansion Study of AG-120", "title": "Agios Presents Data from Dose Expansion Study of AG-120"}, {"url": "http://finance.yahoo.com/news/strong-buy-stocks-november-21st-134301527.html", "publication_date": "2016-11-21 13:43:01 +0000", "summary": "New Strong Buy Stocks for November 21st", "title": "New Strong Buy Stocks for November 21st"}, {"url": "http://finance.yahoo.com/news/apricus-biosciences-aims-resubmit-vitaros-133901261.html", "publication_date": "2016-11-21 13:39:01 +0000", "summary": "Apricus Biosciences Aims to Resubmit Vitaros NDA in 2017", "title": "Apricus Biosciences Aims to Resubmit Vitaros NDA in 2017"}, {"url": "http://finance.yahoo.com/news/arbutus-biopharma-abus-enters-oversold-133501874.html", "publication_date": "2016-11-21 13:35:01 +0000", "summary": "Arbutus Biopharma (ABUS) Enters Oversold Territory", "title": "Arbutus Biopharma (ABUS) Enters Oversold Territory"}, {"url": "http://finance.yahoo.com/news/vivus-vvus-shows-strength-stock-132501191.html", "publication_date": "2016-11-21 13:25:01 +0000", "summary": "VIVUS (VVUS) Shows Strength: Stock Adds 5.1% in Session", "title": "VIVUS (VVUS) Shows Strength: Stock Adds 5.1% in Session"}, {"url": "http://finance.yahoo.com/news/acadia-starts-phase-ii-schizophrenia-141602437.html", "publication_date": "2016-11-16 14:16:02 +0000", "summary": "ACADIA Starts Phase II Schizophrenia Study on Pimavanserin", "title": "ACADIA Starts Phase II Schizophrenia Study on Pimavanserin"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x0k1zHhZ9ng/lilys-jardiance-effective-in-lowering-cardiovascular-death-cm709051", "publication_date": "2016-11-15 00:27:48 +0000", "summary": "Eli Lilly and Company LLY announced that new data presented at the American Heart Association Scientific Sessions 2016 from long term cardiovascular CV outcomes study of its diabetes medicine Jardiance showed that the drug was effective in reducing the risk for cardiovascular death", "title": "Lily's Jardiance Effective in Lowering Cardiovascular Death"}, {"url": "http://finance.yahoo.com/news/lilys-jardiance-effective-lowering-cardiovascular-222310638.html", "publication_date": "2016-11-14 22:23:10 +0000", "summary": "Lily's Jardiance Effective in Lowering Cardiovascular Death", "title": "Lily's Jardiance Effective in Lowering Cardiovascular Death"}, {"url": "http://www.publicnow.com/view/7D947FCDAD82B9BC4AB7FA3F89D059FA4599B305", "publication_date": "2016-11-14 21:07:16 +0000", "summary": "[at noodls] - November 14, 2016 Combinations of Arbutus RNAi and Capsid Assets and Approved Drugs Show Complementary Action Capsid Inhibitor AB-423 Has Dual Mode of Action; Inhibits HBV DNA and cccDNA Synthesis Second ...", "title": "Arbutus Presents HBV Drug Combination Studies at AASLD"}, {"url": "http://biz.yahoo.com/e/161114/abus8-k.html", "publication_date": "2016-11-14 21:03:40 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F2xcOTbwVkY/intrexon-xon-reports-in-line-loss-in-q3-revenues-miss-cm708141", "publication_date": "2016-11-11 22:28:35 +0000", "summary": "Shares of Intrexon Corporation XON have risen more than 4 since it announced its third quarter results Intrexon reported a loss of 24 cents per share in third quarter 2016 which was in line with the Zacks Consensus Estimate However adjusted loss per share was 17 cents compared to", "title": "Intrexon (XON) Reports In-Line Loss in Q3, Revenues Miss"}, {"url": "http://finance.yahoo.com/news/intrexon-xon-reports-line-loss-195807637.html", "publication_date": "2016-11-11 19:58:07 +0000", "summary": "Intrexon (XON) Reports In-Line Loss in Q3, Revenues Miss", "title": "Intrexon (XON) Reports In-Line Loss in Q3, Revenues Miss"}, {"url": "http://finance.yahoo.com/q/is?s=abus", "publication_date": "2016-11-10 18:04:09 +0000", "summary": "ARBUTUS BIOPHARMA CORP Financials", "title": "ARBUTUS BIOPHARMA CORP Financials"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4X7knO3w5eI/puma-pbyi-posts-wider-loss-in-q3-neratinib-in-focus-cm706997", "publication_date": "2016-11-10 14:56:56 +0000", "summary": "Puma Biotechnology Inc PBYI reported a third quarter 2016 loss of 2 02 per share including the impact of stock based compensation expense wider than the Zacks Consensus Estimate of a loss of 2 00 and the year ago loss of 1 87 With no approved products in Puma Biotech s portfolio at", "title": "Puma (PBYI) Posts Wider Loss in Q3, Neratinib in Focus"}, {"url": "http://finance.yahoo.com/news/puma-pbyi-posts-wider-loss-125012431.html", "publication_date": "2016-11-10 12:50:12 +0000", "summary": "Puma (PBYI) Posts Wider Loss in Q3, Neratinib in Focus", "title": "Puma (PBYI) Posts Wider Loss in Q3, Neratinib in Focus"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UD-_kNDfhpU/why-arbutus-biopharma-abus-stock-might-be-a-great-pick-cm706442", "publication_date": "2016-11-09 15:57:22 +0000", "summary": "One stock that might be an intriguing choice for investors right now is Arbutus Biopharma Corporation ABUS This is because this security in the Medical Biomedical Genetics space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank", "title": "Why Arbutus Biopharma (ABUS) Stock Might be a Great Pick"}, {"url": "http://finance.yahoo.com/news/why-arbutus-biopharma-abus-stock-133201530.html", "publication_date": "2016-11-09 13:32:01 +0000", "summary": "Why Arbutus Biopharma (ABUS) Stock Might be a Great Pick", "title": "Why Arbutus Biopharma (ABUS) Stock Might be a Great Pick"}, {"url": "http://www.capitalcube.com/blog/index.php/arbutus-biopharma-corp-abus-us-earnings-analysis-q3-2016-by-the-numbers-november-8-2016/", "publication_date": "2016-11-08 15:43:33 +0000", "summary": "Arbutus Biopharma Corp. :ABUS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016", "title": "Arbutus Biopharma Corp. :ABUS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016"}, {"url": "http://sg.finance.yahoo.com/news/arbutus-reports-3q-loss-103451307.html", "publication_date": "2016-11-04 10:34:51 +0000", "summary": "Arbutus reports 3Q loss", "title": "Arbutus reports 3Q loss"}, {"url": "http://www.publicnow.com/view/2E19E403C2043BB5290415477464104E436FD72A", "publication_date": "2016-11-03 20:34:13 +0000", "summary": "[at noodls] - November 3, 2016 Additional ARB-1467 Multi-Dose Data in 4Q16 Cash Runway into Late 2018 VANCOUVER, B.C. and DOYLESTOWN, Pa., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), ...", "title": "Arbutus Provides Corporate Update and Announces Third Quarter 2016 Financial Results"}, {"url": "http://biz.yahoo.com/e/161103/abus8-k.html", "publication_date": "2016-11-03 20:32:12 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition"}, {"url": "http://finance.yahoo.com/news/patrick-machado-joins-board-directors-200100500.html", "publication_date": "2016-10-19 20:01:00 +0000", "summary": "[PR Newswire] - HAMILTON, Bermuda, Oct. 19, 2016 /PRNewswire/ -- Roivant Sciences Ltd., an innovative biopharmaceutical company focused on developing promising drug candidates to improve the lives of patients and their families, has expanded its Board of Directors through the appointment of Patrick Machado as its second independent director. Prior to joining the board of Roivant Sciences, Mr. Machado was a co-founder of Medivation and served as its Chief Financial Officer from 2004 to 2014. \"We are delighted to welcome Patrick Machado to our board,\" said Vivek Ramaswamy, Founder and Director of Roivant Sciences.", "title": "Patrick Machado Joins Board of Directors of Roivant Sciences"}, {"url": "http://www.investors.com/news/technology/alnylam-halts-drug-testing-after-18-deaths-still-value-in-cousin-drug/", "publication_date": "2016-10-06 20:15:41 +0000", "summary": "Alnylam Halts Drug Testing After 18 Deaths; Value Seen In Cousin Drug", "title": "Alnylam Halts Drug Testing After 18 Deaths; Value Seen In Cousin Drug"}, {"url": "http://www.marketwatch.com/News/Story/Story.aspx?guid=36360712-8BC5-11E6-9D07-90B77F20304B&siteid=yhoof2", "publication_date": "2016-10-06 18:06:58 +0000", "summary": "Alnylam\u2019s discontinued drug raises bigger question about buzzy RNAi approach", "title": "Alnylam\u2019s discontinued drug raises bigger question about buzzy RNAi approach"}, {"url": "http://biz.yahoo.com/e/161006/abus8-k.html", "publication_date": "2016-10-06 14:24:00 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or Pri", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or Pri"}, {"url": "http://biz.yahoo.com/e/161003/abus8-k.html", "publication_date": "2016-10-03 16:49:53 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events"}, {"url": "http://www.publicnow.com/view/DD01D8359D8DADACF7F9848F7BF4DC62CB1165A3", "publication_date": "2016-10-03 12:16:08 +0000", "summary": "[at noodls] - October 3, 2016 VANCOUVER, British Columbia and DOYLESTOWN, Pa., Oct. 03, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions ...", "title": "Arbutus Recognizes Liver Cancer Awareness Month with Grant to Support the Hepatitis B Foundation's Patient Storytelling Campaign"}, {"url": "http://finance.yahoo.com/news/arbutus-recognizes-liver-cancer-awareness-120000171.html", "publication_date": "2016-10-03 12:00:00 +0000", "summary": "[GlobeNewswire] - VANCOUVER, British Columbia and DOYLESTOWN, Pa., Oct. 03, 2016-- Arbutus Biopharma Corporation, an industry-leading Hepatitis B Virus therapeutic solutions company, today announced a partnership with the ...", "title": "Arbutus Recognizes Liver Cancer Awareness Month with Grant to Support the Hepatitis B Foundation\u2019s Patient Storytelling Campaign"}, {"url": "http://finance.yahoo.com/news/arbutus-present-hbv-data-2016-160000588.html", "publication_date": "2016-10-01 16:00:00 +0000", "summary": "[GlobeNewswire] - VANCOUVER, British Columbia and DOYLESTOWN, Pa., Oct. 01, 2016-- Arbutus Biopharma Corporation, an industry-leading hepatitis B virus therapeutic solutions company, today announced presentation of data ...", "title": "Arbutus to Present HBV Data at the 2016 AASLD Liver Meeting"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3PLk73LlvF4/auph-regains-aura-thld-slumps-on-quitting-tarloxotinib-program-cemp-abuzz-20160930-00814", "publication_date": "2016-09-30 00:42:00 +0000", "summary": "AUPH Regains Aura, THLD Slumps On Quitting Tarloxotinib Program, CEMP Abuzz", "title": "AUPH Regains Aura, THLD Slumps On Quitting Tarloxotinib Program, CEMP Abuzz"}, {"url": "http://www.publicnow.com/view/E988605A3DA67021070848E396E5D041EC0AC9F9", "publication_date": "2016-09-29 20:10:04 +0000", "summary": "[at noodls] - September 29, 2016 Single Dose Data Demonstrate Significant Reduction in Serum HBsAg Additive Reductions in Serum HBsAg Observed with Repeat Dosing over 3 Months 5 of 6 Patients in Cohort 1 Had Serum HBsAg ...", "title": "Arbutus Reports Interim Multi-Dose Results from Phase II Clinical Trial of ARB-1467 in Patients with Chronic HBV Infection"}, {"url": "http://biz.yahoo.com/e/160929/abus8-k.html", "publication_date": "2016-09-29 20:02:28 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events"}, {"url": "http://biz.yahoo.com/e/160928/abus8-k.html", "publication_date": "2016-09-28 17:54:09 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stan", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stan"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_61YoYvqeDo/do-you-have-these-biotech-stocks-in-your-portfolio-20160919-00807", "publication_date": "2016-09-19 14:13:00 +0000", "summary": "Do You Have These Biotech Stocks In Your Portfolio?", "title": "Do You Have These Biotech Stocks In Your Portfolio?"}, {"url": "http://biz.yahoo.com/e/160913/abus8-k.html", "publication_date": "2016-09-13 11:01:03 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events"}, {"url": "http://finance.yahoo.com/news/arbutus-chief-scientific-officer-dr-110000885.html", "publication_date": "2016-09-13 11:00:00 +0000", "summary": "[GlobeNewswire] - VANCOUVER, British Columbia and DOYLESTOWN, Pa., Sept. 13, 2016-- Arbutus Biopharma Corporation, an industry-leading Hepatitis B Virus therapeutic solutions company, today announced that Dr. Michael J. ...", "title": "Arbutus\u2019 Chief Scientific Officer, Dr. Michael J. Sofia, Awarded the 2016 Lasker~DeBakey Clinical Medical Research Award"}, {"url": "http://biz.yahoo.com/e/160819/abus8-k.html", "publication_date": "2016-08-19 18:24:40 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement"}, {"url": "http://www.capitalcube.com/blog/index.php/arbutus-biopharma-corp-abus-us-earnings-analysis-q2-2016-by-the-numbers-august-15-2016/", "publication_date": "2016-08-15 17:24:01 +0000", "summary": "Arbutus Biopharma Corp. :ABUS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016", "title": "Arbutus Biopharma Corp. :ABUS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/INqQ8Uclhwk/should-you-get-rid-of-arbutus-biopharma-abus-now-cm664608", "publication_date": "2016-08-12 14:53:51 +0000", "summary": "Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid", "title": "Should You Get Rid of Arbutus Biopharma (ABUS) Now?"}, {"url": "http://finance.yahoo.com/news/rid-arbutus-biopharma-abus-now-123512513.html", "publication_date": "2016-08-12 12:35:12 +0000", "summary": "Should You Get Rid of Arbutus Biopharma (ABUS) Now?", "title": "Should You Get Rid of Arbutus Biopharma (ABUS) Now?"}, {"url": "http://biz.yahoo.com/e/160810/abus8-k.html", "publication_date": "2016-08-10 12:01:48 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events"}, {"url": "http://finance.yahoo.com/news/arbutus-present-2016-wedbush-pacgrow-120000603.html", "publication_date": "2016-08-10 12:00:00 +0000", "summary": "[GlobeNewswire] - VANCOUVER, British Columbia and DOYLESTOWN, Pa., Aug. 10, 2016-- Arbutus Biopharma Corporation, an industry-leading Hepatitis B Virus therapeutic solutions company, today announced that the company will ...", "title": "Arbutus to Present at the 2016 Wedbush PacGrow Healthcare Conference"}, {"url": "http://www.publicnow.com/view/FF81E6E2E78E0A44ADE2C3F9D46965D829834AFD", "publication_date": "2016-08-08 20:49:13 +0000", "summary": "[at noodls] - August 8, 2016 Patent Covers Lipid Particle Compositions Known to be Effective for Delivery of Nucleic Acids Including mRNA VANCOUVER, B.C. and DOYLESTOWN, Pa., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Arbutus ...", "title": "Arbutus Announces Issuance of Broad New US Patent for LNP Delivery Technology"}, {"url": "http://sg.finance.yahoo.com/news/arbutus-reports-2q-loss-104535700.html", "publication_date": "2016-08-05 10:45:35 +0000", "summary": "Arbutus reports 2Q loss", "title": "Arbutus reports 2Q loss"}, {"url": "http://biz.yahoo.com/e/160805/abus8-k.html", "publication_date": "2016-08-05 10:06:56 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9rXAc3eY2rQ/eglt-gets-fda-panel-nod-nxtm-on-a-high-bdsi-ahead-of-schedule-20160805-00049", "publication_date": "2016-08-05 03:11:00 +0000", "summary": "EGLT Gets FDA Panel Nod, NXTM On A High, BDSI Ahead Of Schedule", "title": "EGLT Gets FDA Panel Nod, NXTM On A High, BDSI Ahead Of Schedule"}, {"url": "http://www.publicnow.com/view/204EB0484778660BC6A9E3634F84EC9B651D28DE", "publication_date": "2016-08-04 22:04:04 +0000", "summary": "[at noodls] - August 4, 2016 ARB-1467 Clinical Data in HBV Patients on Track for 2H16 Cash Runway Extends into Late 2018 VANCOUVER, British Columbia and DOYLESTOWN, Pa., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma ...", "title": "Arbutus Provides Corporate Update and Announces Second Quarter 2016 Financial Results"}, {"url": "http://biz.yahoo.com/e/160804/abus10-q.html", "publication_date": "2016-08-04 21:24:07 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 10-Q, Quarterly Report", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 10-Q, Quarterly Report"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wGG5_GTVufA/scln-withdraws-from-auction-block-zfgn-tumbles-double-blessing-for-vrx-20160720-00046", "publication_date": "2016-07-20 02:13:00 +0000", "summary": "SCLN Withdraws From Auction Block, ZFGN Tumbles, Double Blessing For VRX", "title": "SCLN Withdraws From Auction Block, ZFGN Tumbles, Double Blessing For VRX"}, {"url": "http://finance.yahoo.com/news/arbutus-reports-topline-results-tkm-203000283.html", "publication_date": "2016-07-19 20:30:00 +0000", "summary": "[GlobeNewswire] - Promising Anti-Tumor Activity Observed Arbutus to Explore Partnership Options to Enable Further Study. VANCOUVER, B.C. and DOYLESTOWN, Pa., July 19, 2016-- Arbutus Biopharma Corporation, an industry-leading ...", "title": "Arbutus Reports Topline Results from TKM-PLK1 HCC Clinical Trial"}, {"url": "http://finance.yahoo.com/news/arbutus-present-data-lnp-formulations-210000755.html", "publication_date": "2016-07-18 21:00:00 +0000", "summary": "[GlobeNewswire] - In Vivo Data Support Improved Potency of New Lipid Compositions Arbutus\u2019 LNP Platform is the Leading Delivery Solution for mRNA Therapeutics. VANCOUVER, British Columbia and DOYLESTOWN, Pa., July 18, 2016-- ...", "title": "Arbutus to Present Data on New LNP Formulations for Delivery of mRNA at the 2016 Controlled Release Society Conference"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NcA04tyzGVo/andreas-halvorsens-largest-2nd-quarter-buys-cm650288", "publication_date": "2016-07-18 02:08:15 +0000", "summary": "Andreas Halvorsen ( Trades , Portfolio ) is a founding partner of Viking Global Investors LP and currently serves as its CIO. During the second quarter, he traded the following stocks according to GuruFocus Real Time updates. The guru", "title": "Andreas Halvorsen's Largest 2nd Quarter Buys"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZOtvwlF45tE/halvorsen-funds-company-buying-neglected-drugs-gets-stakes-in-2-biotechs-cm649594", "publication_date": "2016-07-16 05:09:08 +0000", "summary": "Andreas Halvorsen ( Trades , Portfolio )AAAs Viking Global Investors said Wednesday it had invested in one of biotechAAAs hottest companies and in the process two of the companies it is involved in. Roivant Sciences, a company dedicated to", "title": "Halvorsen Funds Company Buying Neglected Drugs, Gets Stakes in 2 Biotechs"}, {"url": "http://finance.yahoo.com/news/andreas-halvorsens-viking-global-gets-232050788.html", "publication_date": "2016-07-14 23:20:50 +0000", "summary": "Halvorsen Funds Company Buying Neglected Drugs, Gets Stakes in 2 Biotechs", "title": "Halvorsen Funds Company Buying Neglected Drugs, Gets Stakes in 2 Biotechs"}, {"url": "http://finance.yahoo.com/news/roivant-sciences-appoints-professor-andrew-200100808.html", "publication_date": "2016-07-13 20:01:00 +0000", "summary": "[PR Newswire] - HAMILTON, Bermuda, July 13, 2016 /PRNewswire/ -- Roivant Sciences Ltd. (\"Roivant\"), a biopharmaceutical company focused on realizing the full value of promising drug candidates to improve the ...", "title": "Roivant Sciences Appoints Professor Andrew Lo, PhD as Independent Director"}, {"url": "http://www.publicnow.com/view/6D4355E5D05C4F73653C71B81F0D9A29138D8755", "publication_date": "2016-06-30 12:21:08 +0000", "summary": "[at noodls] - June 30, 2016 In Vivo Data Support Use of Our Proprietary LNP Platform Technology Arbutus Has a Dominant IP Position in LNP-Enabled Delivery VANCOUVER, British Columbia and DOYLESTOWN, Pa., June 30, 2016 ...", "title": "Arbutus to Present mRNA Delivery Data at the 32nd Annual Meeting of the Japan Society of Drug Delivery System"}, {"url": "http://biz.yahoo.com/e/160608/abus8-k.html", "publication_date": "2016-06-08 16:20:48 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement"}, {"url": "http://www.publicnow.com/view/88DF5B281FB8E933FE059BA78725F723A3C2F94B", "publication_date": "2016-06-03 12:05:02 +0000", "summary": "[at noodls] - June 3, 2016 VANCOUVER, British Columbia and DOYLESTOWN, Pa., June 03, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions ...", "title": "Arbutus to Participate in Upcoming Investor Conferences"}, {"url": "http://biz.yahoo.com/e/160603/abus8-k.html", "publication_date": "2016-06-03 12:02:18 +0000", "summary": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits", "title": "ARBUTUS BIOPHARMA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits"}, {"url": "http://www.publicnow.com/view/D71211300B1E472F38881814D5B32293B6F72536", "publication_date": "2016-06-01 12:03:05 +0000", "summary": "[at noodls] - June 1, 2016 First In Vivo Data from Arbutus HBV Preclinical Combination Studies Additive Anti-HBV Effects When Combining Capsid Inhibitor AB-423 with Current Standard of Care VANCOUVER, British Columbia ...", "title": "Arbutus to Present at the 5th Antiviral Drugs Research and Development Conference"}, {"url": "http://sg.finance.yahoo.com/news/arbutus-reports-1q-loss-205425667.html", "publication_date": "2016-05-04 20:54:25 +0000", "summary": "Arbutus reports 1Q loss", "title": "Arbutus reports 1Q loss"}, {"url": "http://www.publicnow.com/view/F68BE22F2DB42C007F9564CE4847C1AEB2A6A193", "publication_date": "2016-05-04 20:10:10 +0000", "summary": "[at noodls] - May 4, 2016 VANCOUVER, British Columbia and DOYLESTOWN, Pa., May 04, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions ...", "title": "Arbutus Provides Corporate Update and Announces First Quarter 2016 Financial Results"}, {"url": "http://www.publicnow.com/view/B3E2732343BA4BF8CFC38624DEF51991D1924E36", "publication_date": "2016-05-03 20:40:05 +0000", "summary": "[at noodls] - May 3, 2016 VANCOUVER, British Columbia and DOYLESTOWN, Pa., May 03, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading hepatitis B virus (HBV) therapeutic solutions ...", "title": "Arbutus Expands HBV Pipeline"}, {"url": "http://www.publicnow.com/view/314AB3C9E1FABDF4E9737DB038414178EDC0B8B8", "publication_date": "2016-04-29 12:18:26 +0000", "summary": "[at noodls] - April 29, 2016 VANCOUVER, British Columbia and DOYLESTOWN, Pa., April 29, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions ...", "title": "Arbutus to Provide a Corporate Update and Release First Quarter 2016 Financial Results"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_Y5syc4zTgE/health-care-sector-update-for-04222016-adap-abus-cm610044", "publication_date": "2016-04-22 13:35:56 +0000", "summary": "Top Health care stocks JNJ 0.2% PFE 0.1% ABT flat MRK flat AMGN 0.3 Health care shares were just lower in pre market trade on Friday. In health care stocks news, Adaptimmune Therapeutics ( ADAP ), a company that", "title": "Health Care Sector Update for 04/22/2016: ADAP, ABUS"}, {"url": "http://www.publicnow.com/view/E39B0C85452B22AAC35F06E758F09F437CB8A125", "publication_date": "2016-04-22 12:16:12 +0000", "summary": "[at noodls] - April 22, 2016 Additional Preclinical Combination Data to be Presented This Year Clinical Combination Studies to Begin in 2017 VANCOUVER, British Columbia and DOYLESTOWN, Pa., April 22, 2016 (GLOBE NEWSWIRE) ...", "title": "Arbutus Presents Data from Combination Activity Studies of HBV Drug Candidates"}, {"url": "http://www.publicnow.com/view/34618713E1B2554D08A7F0811385A027FD30896E", "publication_date": "2016-04-21 22:33:18 +0000", "summary": "[at noodls] - April 21, 2016 VANCOUVER, British Columbia and DOYLESTOWN, Pa., April 21, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions ...", "title": "Arbutus Announces Planned Executive Departure"}, {"url": "http://www.publicnow.com/view/6A51BAD496C9A109A42D64F19868D18171587A40", "publication_date": "2016-04-14 12:29:31 +0000", "summary": "[at noodls] - April 14, 2016 Synergistic Antiviral Activity When Combining AB-423 With Entecavir IND Filing (or Equivalent) Expected in the Second Half of 2016 VANCOUVER, British Columbia and DOYLESTOWN, Pa., April ...", "title": "Arbutus Presents Data on HBV Capsid Assembly Inhibitor AB-423 at EASL 2016"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lING0QfjsJI/will-arbutus-biopharma-abus-continue-to-surge-higher-cm604739", "publication_date": "2016-04-11 22:04:09 +0000", "summary": "As of late, it has definitely been a great time to be an investor in Arbutus Biopharma CorporationABUS . The stock has moved higher by 35% in the past month, while it is also above its 20 Day SMA.", "title": "Will Arbutus Biopharma (ABUS) Continue to Surge Higher?"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XtJyesn1GZo/davita-to-acquire-mountain-view-expand-footprint-in-colorado-cm604701", "publication_date": "2016-04-11 21:05:57 +0000", "summary": "DaVita HealthCare Partners Inc.DVA intends to acquire Mountain View Medical Group to enhance its kidney care services and extend footprint in Colorado Springs. Financial details of the deal remained undisclosed. Per the proposal, Mountain View will be joining the", "title": "DaVita to Acquire Mountain View, Expand Footprint in Colorado"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e-BtNYxICz0/ebola-can-teach-investors-an-important-lesson-about-economic-viability-cm600929", "publication_date": "2016-04-02 19:24:42 +0000", "summary": "Image source  Flickr user UNMEER.  It's been a little more than two years since the fear of an Ebola pandemic gripped the world, but according to the World Health Organization the", "title": "Ebola Can Teach Investors an Important Lesson About Economic Viability"}, {"url": "http://www.publicnow.com/view/ADE0A9F24ADAE1B0A0455B105485296E84C14CCB", "publication_date": "2016-03-30 17:53:30 +0000", "summary": "[at noodls] - March 30, 2016 VANCOUVER, British Columbia and DOYLESTOWN, Pa., March 30, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions ...", "title": "Arbutus to Present Preclinical HBV Data at EASL 2016"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vgrANIUYofc/new-strong-buy-stocks-for-march-14th-cm592627", "publication_date": "2016-03-14 14:45:41 +0000", "summary": "Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) list today Arbutus Biopharma CorpABUSArc Logistics Partners LPARCXBox IncBOXCincinnati Financial CorporationCINFDestination XL Group IncDXLGView the entire Zacks Rank #1 List . Want the latest recommendations from Zacks", "title": "New Strong Buy Stocks for March 14th"}, {"url": "http://www.noodls.com/view/4F29F1717572C9A273ABD3D0F224236745F651B7", "publication_date": "2016-01-25 09:57:04 +0000", "summary": "[at noodls] - Kuros Biosciences Ltd. (SIX:KURN formerly CYTN) ('Kuros') today announced the closing of the acquisition of Kuros Biosurgery Holding Ltd. and the change of name of the combined company to Kuros Biosciences ...", "title": "Kuros Biosurgery Holding Ltd. closes merger with Cytos Biotechnology Ltd. which is renamed Kuros Biosciences Ltd."}, {"url": "http://www.noodls.com/view/239F125059F41A2CC31B0B72FC4298B09874BE90", "publication_date": "2016-01-10 21:16:16 +0000", "summary": "[at noodls] - January 10, 2016 Phase II Multidose Study of ARB-1467 in HBV Patients Was Initiated in 2015 Phase II Single Dose HBsAg Reduction Data Expected in 3Q16 Four HBV Products in Clinical Development by Year-End ...", "title": "Arbutus Provides a Corporate Update and Outlines 2016 Milestones"}, {"url": "http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9LxbrTy_eMA/the-worst-biotech-stocks-in-2015-cm559191", "publication_date": "2015-12-28 19:18:20 +0000", "summary": "Image Source  Wikimedia Commons  Disastrous.  That's the best description for the performance of a handful of biotech stocks in 2015. Four biotech stocks with market caps over $250 million managed", "title": "The Worst Biotech Stocks in 2015"}, {"url": "http://www.noodls.com/view/0863E363FC41D471C39A76EF332B6C7ED24BE01C", "publication_date": "2015-11-05 22:12:12 +0000", "summary": "[at noodls] - VANCOUVER, British Columbia and DOYLESTOWN, Pa., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading therapeutic solutions company focused on developing a ...", "title": "Arbutus Biopharma Announces Third Quarter 2015 Financial Results"}, {"url": "http://www.noodls.com/view/6F210608FC2529C7F52A91968E30870C35CD08AB", "publication_date": "2015-10-15 12:52:10 +0000", "summary": "[at noodls] - VANCOUVER, British Columbia and DOYLESTOWN, Pa., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading therapeutic solutions company focused on developing a ...", "title": "Dr. Michael J. Sofia, Arbutus' Chief Scientific Officer, Named Economist's 2015 Innovation Award Winner in the Bioscience Category"}, {"url": "http://www.noodls.com/view/5B8993E9478F724FE792E635086465F8FF17A483", "publication_date": "2015-10-06 12:44:19 +0000", "summary": "[at noodls] - VANCOUVER, British Columbia and DOYLESTOWN, Pa., Oct. 6, 2015 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading therapeutic solutions company focused on developing a ...", "title": "Arbutus Biopharma Presents Preclinical Data at the 2015 International Meeting on Molecular Biology of Hepatitis B Viruses"}, {"url": "http://www.noodls.com/view/D04F30FDDC718BBCC10751F32EBBD6EE2315EA3C", "publication_date": "2015-10-01 14:38:05 +0000", "summary": "[at noodls] - VANCOUVER, British Columbia and DOYLESTOWN, Pa., Oct. 1, 2015 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading therapeutic solutions company focused on developing a ...", "title": "Arbutus to Present TKM-HBV Data at the 2015 AASLD Liver Meeting"}, {"url": "http://www.noodls.com/view/EA3E0227F1FE108CF3AD50A91C0C412CAAF07B10", "publication_date": "2015-09-09 21:25:11 +0000", "summary": "[at noodls] - September 9, 2015 VANCOUVER, British Columbia and DOYLESTOWN, Pa., Sept. 9, 2015 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading therapeutic solutions company focused ...", "title": "Arbutus to Present at the Baird 2015 Healthcare Conference"}, {"url": "http://sg.finance.yahoo.com/news/tekmira-suspends-ebola-drug-change-202153262.html", "publication_date": "2015-07-20 20:21:53 +0000", "summary": "Tekmira suspends work on Ebola drug, will change name", "title": "Tekmira suspends work on Ebola drug, will change name"}, {"url": "http://sg.finance.yahoo.com/news/tekmira-says-ebola-drug-unlikely-220141025.html", "publication_date": "2015-06-19 22:02:47 +0000", "summary": "Tekmira says Ebola drug unlikely to work in study", "title": "Tekmira says Ebola drug unlikely to work in study"}, {"url": "http://sg.finance.yahoo.com/news/tekmira-stops-adding-patients-african-214409397.html", "publication_date": "2015-06-19 21:44:09 +0000", "summary": "Tekmira stops adding patients in African study of Ebola drug", "title": "Tekmira stops adding patients in African study of Ebola drug"}, {"url": "http://sg.finance.yahoo.com/news/dementia-drug-developer-axovant-climbs-193216564.html", "publication_date": "2015-06-11 23:32:57 +0000", "summary": "Dementia drug developer Axovant climbs after $315M IPO", "title": "Dementia drug developer Axovant climbs after $315M IPO"}, {"url": "http://sg.finance.yahoo.com/news/tekmira-reports-1q-loss-210949640.html", "publication_date": "2015-05-06 21:09:49 +0000", "summary": "Tekmira reports 1Q loss", "title": "Tekmira reports 1Q loss"}, {"url": "http://sg.finance.yahoo.com/news/tekmira-resume-safety-study-ebola-154629495.html", "publication_date": "2015-04-10 15:46:29 +0000", "summary": "Tekmira will resume safety study of Ebola drug within weeks", "title": "Tekmira will resume safety study of Ebola drug within weeks"}, {"url": "http://sg.finance.yahoo.com/news/tekmira-reports-4q-loss-205148873.html", "publication_date": "2015-03-12 20:51:48 +0000", "summary": "Tekmira reports 4Q loss", "title": "Tekmira reports 4Q loss"}, {"url": "http://sg.finance.yahoo.com/news/tekmira-teams-oncore-focus-hepatitis-145236255.html", "publication_date": "2015-01-12 14:52:36 +0000", "summary": "Tekmira teams up with OnCore to focus on hepatitis B cure", "title": "Tekmira teams up with OnCore to focus on hepatitis B cure"}, {"url": "http://sg.finance.yahoo.com/news/tekmira-tops-3q-revenue-forecasts-115739683--finance.html", "publication_date": "2014-11-07 11:57:39 +0000", "summary": "Tekmira tops 3Q revenue forecasts", "title": "Tekmira tops 3Q revenue forecasts"}, {"url": "http://sg.finance.yahoo.com/news/ahead-bell-ebola-treatment-makers-115657764--finance.html", "publication_date": "2014-10-01 11:56:57 +0000", "summary": "Ahead of the Bell: Ebola treatment makers rise", "title": "Ahead of the Bell: Ebola treatment makers rise"}, {"url": "http://sg.finance.yahoo.com/news/shares-companies-testing-ebola-vaccines-222454524--finance.html", "publication_date": "2014-09-30 22:58:35 +0000", "summary": "Shares of companies testing Ebola vaccines rise", "title": "Shares of companies testing Ebola vaccines rise"}, {"url": "http://sg.finance.yahoo.com/news/newlink-genetics-ready-test-ebola-133744137--finance.html", "publication_date": "2014-08-14 20:25:08 +0000", "summary": "NewLink Genetics: Ready to test Ebola vaccine", "title": "NewLink Genetics: Ready to test Ebola vaccine"}, {"url": "http://sg.finance.yahoo.com/news/drugmaker-not-ready-ebola-drug-212734172--finance.html", "publication_date": "2014-08-13 22:06:37 +0000", "summary": "Drugmaker not ready to use Ebola drug in Africa", "title": "Drugmaker not ready to use Ebola drug in Africa"}, {"url": "http://sg.finance.yahoo.com/news/ebola-questions-answers-unproven-drug-110425016--finance.html", "publication_date": "2014-08-12 11:04:25 +0000", "summary": "Ebola: Questions, answers about an unproven drug", "title": "Ebola: Questions, answers about an unproven drug"}, {"url": "http://sg.finance.yahoo.com/news/fda-lifts-hold-experimental-ebola-212648034--finance.html", "publication_date": "2014-08-07 23:26:19 +0000", "summary": "FDA lifts hold on experimental Ebola drug", "title": "FDA lifts hold on experimental Ebola drug"}], "result_count": 171}}